List of Surgical Devices Companies in United States - 221

Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritional and branded generic medicines. Our 114,000 colleagues serve people in more than 160 countries. Connect with us at www.abbott.com, on Facebook at www.facebook.com/Abbott and www.facebook.com/AbbottCareers, on Instagram @AbbottGlobal, and on X @AbbottNews. We invite you to explore opportunities at Abbott, to see if your talents and career aspirations may fit with our openings. An equal opportunity employer, Abbott welcomes and encourages diversity in our workforce. Terms of Use: https://www.abbott.com/social-media-terms-of-use.htm

Access Vascular is offering our suite of vascular access solutions designed to help clinicians address common catheter complications that afflict patients while helping save hospitals time and money.

Actuated Medical has quickly emerged as a leader in the design and development of medical devices and components. Using proprietary actuation technologies, our innovations address a wide variety of medical challenges ranging from clearing occlusions to easing tissue penetration to enabling MRI assisted procedures. From start to finish, our team designs, develops and manufactures under an ISO-certified quality control system. In addition, we continually seek feedback from domain experts to ensure our products not only solve real problems but also are readily accepted by clinicians. With a proven track record of receiving federal grants to support research and development, the company has built a successful business model that takes medical devices from conception to regulatory approval to market.

Admetsys is a biomedical technology company specializing in critical care automation. The company's flagship PrecisionOne system is the first fully automated glycemic control system and continuous blood diagnostics platform for hospital care. The company was founded to commercialize the next generation of medical automation technology: continuous real-time biosensing, robotics, artificial intelligence and learning algorithms, intelligent therapeutic delivery, and advanced data telemetry.

Since 1983, surgeons and neurologists have turned to Ad-Tech for Gold Standard products that help them deliver life-changing care to patients around the world. Our innovative electrodes are used to treat intractable epilepsy, in neurodiagnostics and neurosurgery. With devices ranging from intracranial electrodes for Long Term Monitoring (LTM) and Intraoperative Monitoring, (IONM) and a wide variety of device specifications, we manufacture the devices medical professionals count on for optimal care outcomes. We're humbled by the important role our products can play in the work of caregivers and the lives of their patients. That's why Ad-Tech products are registered and approved for use in more than 60 countries. All are manufactured in the United States. As an ISO 13485 certified company, we observe the highest standards of quality and an unwavering commitment to regulatory compliance. At Ad-Tech, surgeons and their patients always come first.

Advanced Bifurcation Systems Inc. has developed a novel technology to enable effective stenting of coronary arteries at their branch points (bifurcations). This comprehensive platform is a paradigm shift in interventional cardiology that will reduce the need for open-heart surgery, hospitalizations, and repeat coronary angioplasties. The technology will simplify procedures and improve outcomes while reducing angioplasty times which results in significant improvement to the overall patient care at a reduced cost.

Nasal breathing is a very important function of human life and any obstruction in the nasal airway also known as a congested or blocked nose, can dramatically impact the quality of life.The VIVAER treatment, performed in a doctor’s office, is a non-invasive procedure without any incisions. The patient'snasal valve area is gently reshaped using low-temperature radiofrequency energy with lasting results.

Akrivita (formerly SeeTrue), a woman-owned company, specializing in microcapillary needles for precision microinjection. At AkriVita, we've developed the MultiPort Microcapillary Needle using advanced 3D printing and unique resin, ensuring precise and consistent needles. This innovative design eliminates recalibrations, reduces downtime and costs, and minimizes clogging. Our high-contrast needles offer consistent flow, improving the success rates of microinjection procedures. AkriVita provides biomedical scientists and healthcare practitioners with reliable tools that enhance outcomes, save time, and cut costs, enabling them to focus on advancing human health through discovery and innovation.

Alafair Biosciences is a privately-held, commercial-stage medical device company focused on the development of novel clinical products using its proprietary hydrogel technology. With a patent portfolio covering a broad range of clinical applications, Alafair is focused on building a robust product pipeline. Its products are distributed through a dispersed network of independent distributors across the United States.

Allotrope Medical is committed to helping surgeons safely and easily identify the ureter during pelvic operations. The Houston-based company's first product –StimSite™–is designed to assist surgeons in the critical step of ureter identification in millions of operations performed every year. It received funding from Y-Combinator the Mountain View, CA based group that also invested in Door Dash, Dropbox, and Airbnb, and has been voted Top Innovation by a panel of expert surgeons at SAGES (Society of American Gastrointestinal and Endoscopic Surgeons). It also was the past runner-up in the MedTech Innovator contest out of over 600 companies from around the world, and took home top prize at the 2020 Texas A&M New Ventures Competition. Our vision is to advance smooth muscle stimulation technology as the standard of care to help improve minimally invasive surgical outcomes and drive healthcare efficiency. We are building a dynamic team of high performing, accountable, attentive individuals looking to serve patients, partners and institutions in focused surgical specialty markets.

Allurion was founded in 2009 with one mission: end obesity. The Allurion Program combines medical, digital, and nutritional approaches and engages an entire team to jumpstart weight loss and form lifelong healthy habits. Allurion has already helped thousands of people around the world lose weight, develop lifelong healthy habits, and transform their lives, with over 100,000 balloons placed, and over 1,000,000kg lost worldwide.

Alpha Medical Instruments,developer, manufacturer, Balloon flotation catheters, venous catherization, right heart, measurements, venous, pulmonary artery pressures, cardiac output

ATEC is a medical device company dedicated to revolutionizing the approach to spine surgery through innovation. ATEC’s Organic Innovation Machine™ is the greatest concentration of spine knowhow in the industry and committed to the creation of clinical distinction. Leveraging 100% spine focus and expertise, we seek to improve spine surgery by rethinking, redesigning and seamlessly integrating the technologies required from the ground up. The innovation that results from that process is being rapidly adopted because, like us, spine surgeons covet informatic and procedural sophistication that enables more predictable, more reproducible care. Our flagship technology, the Prone TransPsoas (PTPTM) Procedure, leveraged decades of experience to advance first-generation lateral surgery with a more familiar patient position and elevated neuromonitoring.   EOS imaging, the backbone of ATEC’s informatic ecosystem, provides radiographic imaging, enabling standing, full-body, global alignment assessments. We are further developing EOS technology to elevate spine care with unprecedented capabilities. Our vision is to be the standard bearer in spine. Visit our website for more information: www.atecspine.com

The mission of Alume Biosciences is to make our proprietary nerve illumination technology available for surgeons so that patients everywhere can benefit. Learn how you can help us move surgery into the light.

Amend Surgical leads the biopharmaceutical industry in promoting development of bone healing with NanoFuse, a bone graft substitute and bone void filler.

AVS is an early-stage medical device company focused on safely and effectively treating severely calcified arterial disease. It was founded in 2018 by Hitinder Gurm, M.D., Interventional Cardiologist and Chief Clinical Officer at University of Michigan, and Robert Chisena, Ph.D., Chief Technical Officer at AVS. We are redefining interventional therapy for severely calcified lesions with our Pulse IVL System, which uses a novel pulsatile mechanism of action to shatter calcium and expand narrowed vessels, all with a single device. To learn more about pulsatile intravascular lithotripsy, visit www.avspulse.com.

This unique mechanical surgical clamping technology is delivered directly through a fine, minimally invasively, 18 G needle for clamping of blood vessels, ducts, arteries, and veins. The minimally invasive needle delivery results in secure occlusion similar to that of a transfixion suture. SCureClamp with iDOT's anchoring feature secures the implant in place and eliminates slippage. Grasping allows physicians to occlude vessels of varying sizes, types, and wall thickness.

Established in 1993 in California, USA, Amsino is a leading medical device developer and manufacturer dedicated to advancing healthcare worldwide by developing, manufacturing, and marketing medical products that help improve the safety and effectiveness of patient care. The Amsino product portfolio includes Sterile Water and Saline, IV Therapy, Waste Fluid Management, Respiratory, Urology, and Enteral Feeding products. Amsino products are distributed in the United States and more than 80 countries worldwide. Visit www.amsino.com for our complete product offering.

Stem cell renewal, maintenance and tissue regeneration are critical for normal health and well-being. Wnt pathway interactions are crucial to maintenance of these processes. Ankasa is the first to produce human Wnt proteins in a manufacturing setting suitable for use in humans, leading to clinical candidate ART352-L. Successful development of ART352-L will enhance the osteogenic properties of patient derived stem cells used in reconstructive surgeries and provide safe and effective enhancement of bone formation in indications for which this is a significant unmet medical need.

Apollo Endosurgery, Inc. is a medical technology company focused on development of next-generation, less invasive devices to advance therapeutic endoscopy designed to treat a variety of gastrointestinal conditions including closure of gastrointestinal defects, managing gastrointestinal complications and the treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, X-Tack TM Endoscopic HeliX Tacking System and the ORBERA® Intragastric Balloon.

Applied Surgical Robotics is a MedTech company focused on developing robotic technology and SaaS software solutions to improve surgical precision.

Aria CV, Inc: Improving the lives of patients suffering from the disease of pulmonary hypertension.

Artivion is a leader in the manufacturing, processing, and distribution of medical devices and implantable tissues used in cardiac and vascular surgical procedures focused on aortic repair. Our purpose is to develop simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with diseases of the aorta and deliver breakthrough technologies of unsurpassed quality that have far-reaching impact. Our decades of expertise in treating aortic diseases—coupled with our recent acquisitions and partnerships—have empowered us to offer cardiac and vascular surgeons a suite of aortic-centric solutions such as cryopreserved cardiac and vascular allografts, surgical sealants, prosthetic heart valves, and aortic stents and stent-grafts. Artivion has over 1,250 employees worldwide with sales representation in over 100 countries. The Company has manufacturing facilities located in Atlanta, Georgia, Austin, Texas, and Hechingen, Germany. Additionally, it has sales and distribution offices in various countries throughout Europe, Asia, and South America.

Asensus Surgical is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™ by unlocking the Clinical Intelligence to enable consistently superior outcomes and a new standard of surgery. This builds upon the foundation of Digital Laparoscopy with the Senhance® Surgical System powered by the Intelligent Surgical Unit™ (ISU™) to increase surgeon control and reduce surgical variability. With the addition of machine vision, augmented intelligence, and deep learning capabilities throughout the surgical experience, we intend to holistically address the current clinical, cognitive and economic shortcomings that drive surgical outcomes and value-based healthcare. Learn more about Performance-Guided Surgery and Digital Laparoscopy with the Senhance Surgical System here: www.Senhance.com. Now available for sale in the US, EU, Japan, Russia, and select other countries. For a complete list of indications for use, visit: https://www.senhance.com/indications.

AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 37 million people worldwide. Electrophysiologists, cardiothoracic and thoracic surgeons around the globe use AtriCure technologies for the treatment of Afib, reduction of Afib related complications and post-operative pain management. AtriCure's Isolator® Synergy™ Ablation System is the first medical device to receive FDA approval for the treatment of persistent Afib. AtriCure's AtriClip® Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide. AtriCure's Hybrid AF™ Therapy is a minimally invasive procedure that provides a lasting solution for long-standing persistent Afib patients. AtriCure's cryoICE cryoSPHERE®+ and cryoSPHERE MAX™ probes are cleared for temporary ablation of peripheral nerves to block pain, providing pain relief in cardiac and thoracic procedures. For more information, visit AtriCure.com or follow us on X (formerly Twitter) @AtriCure.

A devision of ATTWILL Vascular Technologies, Attwill Medical Solutions purchased the assets of Anteco Pharma facility In 2017. Attwill Medical Solutions specializes in the lyophilization and related processing of pharmaceutical intermediates, medical devices and specialty food and nutritional ingredients. ATTWILL operates a fully integrated commercialization business within a 36,500 square foot facility that includes R&D laboratories, piloting facilities and seven ISO 7 cleanrooms for manufacturing. Our ISO 13485 2016 manufacturing includes six freeze dryers that are used in the processing of ATTWILL products and in contract manufacturing of products that include pharmaceuticals, drug ingredients, medical devices, and nutraceuticals

Augmedics pioneers cutting-edge augmented reality technologies to improve surgical outcomes. The company's revolutionary xvision Spine System® allows surgeons to see patients' anatomy as if they have "x-ray vision" and accurately navigate instruments and implants during spine procedures. The first-of-its-kind, FDA-cleared xvision has been used to treat over 4,000 patients and implant more than 20,000 pedicle screws across 21 US states. Augmedics has received numerous honors, including being named a 2021 Index Awards Finalist, a Fast Company World Changing Ideas Awards 2021 Finalist, and one of Time Magazine's Best Inventions of 2020. It was recently featured in The Economist documentary How will businesses use the metaverse? To learn more or schedule an xvision demo, visit augmedics.com.

Avenu Medical is a well-established medical device company dedicated to creating a paradigm shift in vascular access for hemodialysis patients. Our focus is to pursue unmet clinical needs by developing a minimally invasive, cost effective and efficient approach to vascular access. Founded in 2010 and headquartered in Orange County, California, we have developed the Ellipsys® Vascular Access System, an innovative, image-guided, single catheter system used to percutaneously create an arteriovenous (AV) fistula for hemodialysis access. Over the past three years, the Ellipsys System has been used in clinical trials outside the United States. In December 2014, we received approval from the Food and Drug Administration (FDA) to begin a pivotal Phase III clinical trial in the United States through an Investigational Device Exemption (IDE). Patient enrollment for the trial was completed in June 2016. The Ellipsys System has received FDA approval and European CE Mark approval for the creation of an arteriovenous fistula in patients with chronic kidney disease requiring hemodialysis.

Avinger, Inc. is a commercial-stage medical device company that designs, manufactures and sells image-guided, catheter-based systems for the treatment of patients with peripheral artery disease (PAD). PAD is characterized by a build-up of plaque in the arteries that supply blood to the arms and legs. The company’s mission is to radically change the way vascular disease is treated through the introduction of products based on its lumivascular platform, the only intravascular image-guided system of therapeutic catheters available in this market. Avinger’s current lumivascular products include the Lightbox imaging console, the Ocelot family of catheters, which are designed to penetrate total arterial blockages, known as chronic total occlusions, or CTOs, and Pantheris, the first-ever image- guided atherectomy device, designed to precisely remove arterial plaque in PAD patients.

Axcess Surgical is a medical devices company that specializes in creating advanced surgical innovations for optimum results.

Axon Therapies is addressing a root cause of heart failure with their frontline therapy by selectively ablating the neural pathway carrying information from the chronically hyperactive sympathetic nervous system (SNS) in order to restore volume balance, stop disease progression and improve symptoms

At Best nomos we design products and solutions that help medical professionals treat a variety of cancers. We are best known for our innovations in IMRT and IGRT. As one of the newest members of the Best family of companies, our aim is to expand our product selection beyond imaging technology to become the Single Source Oncology Solutions provider of choice for our customers.

AT BIOREP, WE MAKE PRODUCTS THAT ENHANCE - AND SAVE - LIVES. Beginning with our shared passion for health, we believe in making life better by innovating and developing new biomedical tools, and improving and understanding surgical techniques.

Medical device design and development. First patented product under development is BondTrue, which standardizes surgical closure for better wound healing. Unlike other closure techniques, BondTrue knows where the incision was made so it can precisely realign the wound back together, reducing wound complications, saving time and costs.

We are part of bess group (www.bessgroup.com), a group of dynamic and developing companies, headed by our holding company bess AG (Berlin, Germany). It is our vision to provide life sciences products of high value yet cost-effective, enabling us to become market leaders in as many of our medical fields as possible. Though much has changed at Boston Medical Products over the past 39 years, one thing remains constant: our commitment to deliver the world's finest specialty surgical products - products that clinicians rely on and patients can trust. Founded in 1980 by three physicians - including world-renowned ENT surgeon William W. Montgomery, M.D. - as a way to make Dr. Montgomery's original innovations widely available, Boston Medical Products continues to be driven by his life-long commitment to superior patient care. Over the years since our beginning, we have expanded our line of products with innovations from some of the world's leading physicians, health care innovators, and opinion leaders. Boston Medical Products today develops, manufactures and sells many different types of specialty products that meet the exacting needs of clinicians specializing in Otolaryngology, Pulmonary Medicine, Respiratory Therapy and Speech Pathology. In the established patient oriented tradition, Boston Medical Products has developed an educational website www.trachs.com as a service to provide patients with the very best products and resources for their laryngectomy and tracheostomy needs. It is a website where you can not only find the products you need for your care and comfort, but information and support that will help you make decisions and improve your quality of life.

Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of health care. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions.

Bravida is redefining what's possible in wound care and infection prevention, with a portfolio of transformative products and technologies that are clinically proven to deliver uncompromising freedom and protection

CairnSurgical, Inc. is a clinical stage medical device company developing patient-specific surgical guides using patient imaging data and state-of-the-art 3D printing technologies. CairnSurgical's Breast Cancer Locator System enables precise tumor localization and excision, and has been tested in both single-arm and randomized clinical trials. The Breast Cancer Locator is considered an investigational device in the U.S. and is limited by U.S. law to investigational use only. It is not approved for sale in any region.

Caldera Medical is a medical device company solely focused on women's health with a commitment to our mission of "Improving the Quality of Life for Women!" We develop, build and market best in class surgical products for the treatment of Stress Urinary Incontinence and Pelvic Organ Prolapse. Working closely with surgeons to help those here at home, as well as women around the world, through our humanitarian programs to give them the access to the education and treatment they deserve. Mission - To Improve the Quality of Life for Women Vision - To be the Global Leader in Women's Pelvic Health Values "C4"​ - Care / Collaborate / Challenge / Create

Cannuflow is a healthcare technology company that offers innovative fluid management solutions for knee, shoulder, and hip arthroscopy procedures.

At Capstan Medical, we’re driven by an unwavering commitment to transforming the treatment of structural heart disease. By merging surgical robotics with catheter-based technology and next generation implants, we’ve pioneered a patient-optimized approach to repair and replace heart valves.

Delivering cutting-edge cardiac medical devices to clinicians since 1994. CardioCommand Inc., headquartered in Tampa, Florida, is a pioneering medical technology company dedicated to revolutionizing cardiac care. Established in 1994, CardioCommand has established itself as a leading innovator in the field of cardiovascular health, leveraging cutting-edge advancements in medical technology to enhance patient outcomes and streamline medical procedures. At CardioCommand, our mission is to empower healthcare professionals with state-of-the-art cardiac monitoring solutions, ensuring timely and accurate diagnoses while prioritizing patient comfort and well-being. We are committed to advancing the standard of care in cardiovascular medicine through innovation, integrity, and excellence.

CardioFocus is a medical device innovator and manufacturer dedicated to advancing ablation treatment for cardiac disorders such as atrial fibrillation (AFib), the most common heart arrhythmia. The company's FDA-approved HeartLight Endoscopic Ablation System has successfully treated more than 10,000 patients in the United States, Europe and Japan. The HeartLight System is a revolutionary catheter ablation technology that along with direct visualization and titratable laser energy, represents a new standard for AFib ablation. CardioFocus is headquartered in Marlborough, MA. For more information, visit www.CardioFocus.com. Social Media Community Guidelines: bit.ly/2IDIBZR

Cerapedics is a global, commercial-stage orthopedics company that aspires to redefine the standard of care for bone repair by healing bones faster and at higher rates, without compromising safety, so that patients can live their healthiest lives. Bone grafts, including Cerapedics’ products, are used in over four million annual spine, orthopedics, trauma and interventional procedures world-wide. Cerapedics’ product, i-FACTOR®, is FDA approved for single-level cervical spinal fusions in the United States. Cerapedics’ next-generation product is currently being evaluated for use in lumbar interbody fusion through ASPIRE, a pivotal IDE study, and has been granted a Breakthrough Device Designation by the FDA. Cerapedics is headquartered in Westminster, CO.

ClearFlow, Inc. is a medical device company that specializes in innovative surgical drainage solutions. Founded in 2007 by cardiothoracic surgeons Dr. Edward Boyle and Dr. Marc Gillinov, the company focuses on improving outcomes in cardiac surgery by addressing complications related to retained blood and fluids after surgery. The company's primary offering is the PleuraFlow Active Tube Clearance System, a chest tube designed with Active Clearance Technology (ACT). This system helps maintain patency and prevent occlusions, reducing the risk of "failure to drain" events that can lead to longer hospital stays and increased costs. ClearFlow's products are targeted at hospitals and healthcare facilities performing cardiothoracic surgeries, particularly in intensive care units. Led by President and CEO Paul Molloy, ClearFlow is committed to developing devices that enhance patient recovery and reduce healthcare costs. The company has received FDA 510(k) clearance and the CE Mark for its PleuraFlow system, reflecting its dedication to providing reliable solutions for clinicians.

Clear Guide Medical is a leader in next-gen medical imaging fusion and navigation technology. Our vision-based approach has been introduced in a family of clinical guidance products, including the CLEAR GUIDE SCENERGY for instrument guidance and SCENERGY FUSION for ultrasound and CT/MRI image fusion. Our products make minimally-invasive interventions like biopsies, ablations, pain injections, and peripheral nerve blocks efficient and cost-effective. The company is a privately-held spinout of the Johns Hopkins Medical Institutions and The Johns Hopkins University based in Baltimore, Maryland.

A surgical device company dedicated to cutting costs, prioritizing patients, and simplifying surgery.

Perfecting the Sense of Sight. Clerio Vision is developing a revolutionary product platform for the global ophthalmic market, based on technology licensed from the University of Rochester. The company is in the process of developing and commercializing a portfolio of next generation products in contact lenses, myopia control and cataract surgery. The team is composed of serial entrepreneurs with multiple exits as well as ophthalmic industry veterans who pioneered a number of new ophthalmic technology categories. The products are currently in clinical development.

CoapTech is bringing a series of breakthrough medical devices to worldwide markets, leveraging a patented, disruptive platform technology called the Point-of-care Ultrasound Magnet Aligned (PUMA) System. The PUMA Platform will disrupt multiple medical procedures, reducing health care costs, and improving efficiency, safety, quality, patient experience, and access to services around the globe. Invented by Dr. Steven Tropello, a Johns Hopkins-trained critical care physician, the PUMA System enables diagnostic, interventional and therapeutic procedures in hollow organs. The system combines magnetic attraction for device placement guidance, and ubiquitous, low-cost, point-of-care ultrasound for visualization in hollow cavities. Our lead device, the PUMA-G, selected because of its low risk, clear FDA pathway, and strong commercial viability, is for the insertion of Gastrostomy (feeding) tubes. PUMA-G enables a point-of-care (i.e. bedside, as opposed to operating room) procedure for inserting gastrostomy tubes which can be quickly and easily performed by non-surgical providers. By eliminating specialty suites and specialist consultants, PUMA-G will save hospitals money and improve efficiency and safety for this common procedure. PUMA-G has been validated in human anatomy, and has a streamlined regulatory pathway based on FDA presubmission feedback.

CompactCath is a medical device company committed to improving the quality of life for self-catheterizing patients, their families, and healthcare providers. Designed and founded at Stanford University by a team of physicians, engineers, and catheter users, we are driven by a goal to design medical devices that enable those with chronic conditions to lead active, thriving, independent lives. CompactCath, our flagship intermittent urinary catheter, is a revolutionary pre-lubricated, non-touch catheter for users looking for a compact, discreet, and easy to use solution that fits seamlessly in their lives. CompactCath is FDA cleared in the US and CE approved in Europe. For more information, visit our website: www.compactcath.com and watch our video: https://www.youtube.com/watch?v=k8cjjgfGhAY

CoNextions Medical is focused on developing novel solutions for tendon repair. For almost 2,000 years, suture has been the standard of care for the repair of injured tendons. We believe it is time for something new.

Conformal Medical develops medical devices to prevent stroke in patients with non-valvular atrial fibrillation. The company's proprietary technology will help left atrial appendage closure meet its true potential.

At Cook, we are building our future on Invention, Connection, People, and Community. As a privately owned company, we can look at the world our own way and do what we feel passionate about. What are we passionate about? That’s simple: Making unique, quality products and connecting with people to improve lives on both sides of the device. Central to our focus on building deep connections is our belief in the importance of identifying innovative solutions to help customers, patients, employees, and communities thrive. We understand that our ongoing success will come from creating inclusive, supportive, and healthy environments where we can prosper together. Our people are our greatest asset and are at the heart of everything we do. Come build with us.

CooperSurgical is driven to advance the care of women, babies, and families around the world. We believe in empowering individuals and healthcare professionals in making health and life choices. We are trusted by clinicians worldwide for products, technologies, and services that support a wide range of reproductive solutions, from contraception to fertility and preventative and therapeutic gynecological care.

Cordis is a medical devices company that specializes in cardiology equipment and healthcare technology.

Cortex aims to transform the diagnosis and treatment of atrial arrhythmias by providing insight into each individual patient's disease pathophysiology. The OptiMap™ System is a 510k cleared, electrographic flow mapping solution designed with AI, enabling physicians to See What Matters.

Corza Medical's mission is to aid and champion the surgical community with outstanding products and remarkable service that save time, money and effort. We are a leading provider of medical devices and Biosurgery serving surgeons and their teams, distributors and OEM partners around the world. With our expanding platform of industry-leading brands, including Quill® barbed sutures, Sharpoint® and Look™ surgical sutures, Katena® reusable ophthalmic instruments, Sharpoint ophthalmic knives, the TachoSil® fibrin sealant matrix, as well as Pearsalls and FSSB OEM solutions, Corza Medical delivers an exceptional customer experience and outstanding value to the entire surgical community. Find out more at http://corza.com

Cynosure is a leader in the medical devices industry specializing in aesthetic medicine and cosmetic procedures.

CystoSure is a novel device specifically designed for safe, efficient and standardized visualization of the female bladder and ureteral openings. Building off of a traditional Foley catheter design, CystoSure introduces a whole new means of safely and comfortably evaluating the female bladder.

Duke University spin-out, Deep Blue Medical Advances has developed a novel hernia mesh to address the unacceptably high rate of hernia occurrence and recurrence. Millions of hernia surgeries are done globally with billions of dollars in clinical cost. Our surgeon-invented T-Line® Hernia Mesh with integral suture-like extensions is designed to eliminate a key point of failure for conventional mesh fixation - the mesh, suture, tissue interface - and to provide superior anchor strength. In addition, several additional products are in development, including an anchor clip for even faster, easier implantation; a biosynthetic version of the T-Line Hernia Mesh; and a coated composite version of the T-Line Mesh. Deep Blue products enhance hernia surgery with a potentially significant impact on the $1.1B global hernia device market. Due to its simple yet revolutionary design, the T-Line® Hernia Mesh has the potential to reduce hernia occurrence and recurrence by preventing or reducing mesh fixation failure.

DuraStat is a surgical device that enables higher-quality, gold standard dural repairs with efficiency, even when access is limited. This is facilitated by the needle and suture, being retained within the smooth, curved tip enabling pre-selection of optimal location for needle placement and suture passage. DuraStat consolidates steps and facilitates suture passage with a button-press, helping save time and eliminating supination. Sutured repairs are the best-known way to prevent persistent CSF leaks. DuraStat helps gain control of the tear with optimal suture placement and minimized tissue disruption. What Are Surgeons Saying "Any day with a dural tear is a bad one. DuraStat can simplify repairs in difficult locations. It allows for a better repair with greater efficiency. With that comes improved patient outcomes." Mark B Kerner, MD | Bon Secours Maryview Medical Center "Every spine surgeon would benefit from having this tool available." Alex Vaccaro, MD, PhD, MBA | Thomas Jefferson University "It significantly reduces the learning curve, allowing trainees and less experienced surgeons to quickly and safely repair a durotomy. Both fellows and attendings like it, demonstrating its long-term value to surgeons." Christopher DeWald, MD | Rush University Contact us at info@durastat.com. DuraStat partners with clinicians, hospitals and health systems to help improve outcomes for patients. We look forward to working with you.

The company works with doctors to develop medical devices related tostructural heart disease and critical care monitoring.

Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of health care. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. For more information, visit www.bostonscientific.com and connect with us on X, Instagram, and Facebook. At Boston Scientific, you will find purpose, a place to grow and opportunities to cultivate your passions. To search and apply for open positions, visit https://bostonscientific.eightfold.ai/careers. You may also review our social media guidelines at http://www.bostonscientific.com/social.

ENCOLL CORP. is a medical devices company based out of 4576 ENTERPRISE STREET, FREMONT, California, United States.

Endomedix is a development stage, Medical Device venture, a C corp. The Company has developed a tunable polysaccharide platform that can produce a family of new biomaterials. The first spinoff of this platform is PlexiClot™ Absorbable Hemostat to control bleeding in brain & spinal surgeries, a $1.9B market. PlexiClot introduces the first fundamental innovation in bleeding control in these procedures since the current standard of care was introduced in 1945. The innovation is based on new mechanisms of action that will likely obsolete the current methods of relying on the biochemical action of thrombin and manual pressure to produce coagulation. PlexiClot will eliminate one cause of reoperations caused by current devices as documented in dozens of clinical publications. In addition to reducing the incidence of complications, PlexiClot is poised to save hospitals hundreds of millions of dollars in unreimbursed costs due to reoperation, lengthy hospital stays and early readmission to hospitals. PlexiClot's performance has been confirmed in 3 large animal trials, and Endomedix is currently planning to scale up production. PlexiClot's composition of matter, method of manufacture and mechanisms of action are protected by 8 issued patents, the most important of which expire in 2038. The Endomedix team is led by Richard Russo, a medical device vet with experience in prior start-ups with exits, and he is the lead cash investor. He has a history of success with new products, clinical & regulatory, and international. R&D is led by Piyush Modak, who leverages a small internal team through a constellation of renown subject matter experts. 18 neurosurgeons & physicians are investors. PlexiClot will be the 1st device approved by FDA specifically for brain surgery. This sector is marked by a high level of M&A activity, much of which occurs prior to final FDA approval. The program has drawn interest & support from surgeons and physicians, 18 of whom are investors.

EndoQuest Robotics has developed the Flexible Robotic Surgery (FRS) System, an endoluminal robotic surgical system that makes it possible for therapeutic endoscopists and surgeons to perform minimally invasive surgery within the gastrointestinal tract. EndoQuest's robotic platform combines the flexibility of endoscopy that is able to navigate the curvature of patients' anatomy with instrumentation that allows the physician to use a conventional two-handed surgical technique. EndoQuest's FRS has further potential applications in a range of endoluminal surgeries including appendectomy and cholecystectomy that can be performed with no external incisions. For additional information, visit the Company's website at www.endoquestrobotics.com. EndoQuest's FRS System is under development, has not been cleared by the FDA, and is not for commercial sale in the United States.

EndoTheia was founded in 2018 to develop the next generation of flexible endoscopic devices, with the goal of increasing therapeutic yields through added flexibility and dexterity.

Enovis is a data analytics company that provides technology solutions for business intelligence and information management.

Escalon, operates in the healthcare market, develop, manufacture, marketing, and distribution of medical devices for use in ophthalmology.

Field Medical, Inc. is a medical technology company based in Cardiff-by-the-Sea, California, focused on developing advanced pulsed field ablation (PFA) systems for treating cardiac arrhythmias. Founded in 2022 by Dr. Steven Mickelsen, a pioneer in PFA technology, the company is dedicated to improving catheter-based ablation therapies to meet clinical needs. Field Medical has made significant progress, moving from preclinical development to clinical trials, and has secured substantial funding to support its initiatives. The company's flagship product, the FieldForce Ablation System, includes the FieldForce Catheter and FieldForce Generator. The catheter is designed for ventricular arrhythmias, providing precise lesion formation with real-time force feedback. The generator utilizes proprietary FieldBending™ technology to deliver high-intensity pulsed electric fields, targeting arrhythmias while minimizing damage to surrounding tissue. Field Medical's clinical programs focus on ventricular tachycardia and atrial fibrillation, with promising early results from pilot studies and ongoing first-in-human trials. The company aims to establish PFA as the standard of care in cardiac ablation, leveraging its innovative technology and strategic funding to enhance its market presence.

Fluke Biomedical manufactures biomedical test and simulation products, including electrical safety testers, patient simulators & performance analyzer.

Francis Medical is developing minimally invasive treatment solutions for prostate, kidney, and bladder cancer through the use of convective thermal water vapor. Currently, the company is in clinical trials for ablating cancerous prostate tissue. Founded in 2018, Francis Medical is located in Maple Grove, Minnesota. Francis Medical, Inc., formerly named NxPhase Medical, Inc., is a company that was created after Boston Scientific (BSC) acquired NxThera, Inc. in April of 2018. As a part of the BSC/NxThera transaction, a separate and independent entity, NxPHASE Medical, Inc. (“NxPHASE”), was established, and shares of NxPHASE were distributed to the shareholders of BSC/NxThera. In addition, BSC/NxThera granted NxPHASE a license to utilize BSC/NxThera’s convective vapor ablation technology to develop, evaluate, and commercialize certain devices to treat prostate, kidney and bladder cancer (“NxPHASE Field of Use”), while BSC/NxThera remains focused on the treatment of benign prostatic hyperplasia. Late in 2018, NxPhase Medical, Inc. went through a rebranding process and selected Francis Medical, Inc. as its new brand and identity. The name and foundation of the company are a tribute to and legacy of Michael Hoey’s (founder/inventor) father, Francis Hoey, whose life was ended by prostate cancer with treatments that had harsh implications on his normal daily living.

Freudenberg Medical is a global partner for the design, development and manufacture of medical devices, components, and minimally invasive product solutions. Our comprehensive technical capabilities range from the design and manufacture of minimally invasive, catheter, and handheld technology to the development and production of medical components utilizing advanced materials and processes. We are an industry leader in the manufacture of high precision silicone and thermoplastic components and tubing as well as metal hypotubes and coating technology. Freudenberg Medical is part of the Freudenberg Group, a global technology group. As an organization, we ensure that every project is supported by our unmatched range of global resources, financial stability, and the flexibility to optimize for business performance. www.FreudenbergMedical.com Explore the possibilities with Freudenberg Medical, please call 877-308-0558 or email info@freudenbergmedical.com

Freyja’s mission is to raise the standard of women’s health in both surgical and in-office procedures, enabling physicians to deliver safe and effective care.

Galen Robotics is developing a single-platform solution to aid surgeons across several disciplines with minimal disturbance to existing workflows. Our cooperative control paradigm aims to eliminate hand tremor and enable surgeons to realize precise minimally invasive interventions in otolaryngology, head and neck surgery, and tissue reconstruction that were previously considered beyond human capacity.

Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite for use as a standalone procedure in patients with refractory glaucoma; iStent SA, a two-stent product that is designed for use as a standalone glaucoma procedure; iDose Travoprost, a targeted injectable implant based on its micro-scale device-platform that is designed to deliver therapeutic levels of medication; and MicroShunt, an ab-externo device for treatment of open-angle glaucoma. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was founded in 1998 and is headquartered in San Clemente, California.

Gore Medical makes medical devices used by healthcare professionals to improve the lives of patients worldwide. Come and learn more about our work.

GT Medical Technologies, Inc. (GT), an Arizona-based medical device company, is focused on improving the lives of patients with brain tumors. GT has developed an innovative approach to treatment by combining a conformable collagen matrix with brachytherapy (radiation) seeds. The product has the promise to revolutionize treatment for 176,000 patients/year in the US alone. To date, we have treated 1000+ patients with brain tumors.

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

HAPPE is an emerging leader of next generation orthopaedic and spinal implants enabled by the HAPPE™ (HydroxyApatite Porous PolyEtheretherketone) platform. The HAPPE material platform offers interconnected, cancellous porosity with exposed hydroxyapatite on pore surfaces to enable robust bone in-growth and on-growth confirmed in preclinical testing.

H.B. Fuller | Adhezion Biomedical, LLC is a medical device company focused on the development and commercialization of highly differentiated cyanoacrylate based surgical, wound management and infection prevention technologies. Founded in 2001, the company is based in Wyomissing, Pennsylvania. The vision of the Adhezion team is to redefine the way cyanoacrylate based surgical adhesives and sealants are used in medicine. Our mission is to provide technologies that achieve optimal patient outcomes. Adhezion currently is developing and commercializing cyanoacrylate‐based adhesives and sealants for use in both professional and consumer healthcare settings.

Established in 1996 and located along Route 128 in MA, HAI Laboratories, Inc. is the only American manufacturer of clinical, eye bank and laboratory specular microscopes in operation today. We are also known for our advanced software systems for image processing and analysis, digital video slit lamps and high quality ophthalmic microsurgical instruments.

The Future of Microsurgery is Robotics and AI. Horizon Surgical Systems, founded in 2021 by experts in ophthalmology and medical robotics, is at the forefront of innovation in microsurgery. Our groundbreaking product, Polaris, leverages state-of-the-art robotics, advanced medical imaging, and AI to extend the capabilities of surgeons beyond their current limitations. With a foundation rooted in academic excellence and a vision for the future, Horizon is committed to revolutionize global healthcare through technological innovation, bringing a new era of precision, enhanced outcomes, and safety to eye care.

Hospi is a healthcare technology company that innovates practical medical devices to enhance patient comfort and wellbeing, ease caregiver burden, and reduce cost.

HydroCision, Inc. is a privately held medical device company focused on the development and commercialization of its proprietary fluidjet technology for sports medicine and spine applications. The tissue differentiating technology delivers a hair-thin, high velocity, nonthermal stream of saline to cut and simultaneously aspirate tissue without external suction. Application specific devices are designed to remove diseased tissue without harming surrounding healthy tissue in a minimally invasive manner. HydroCision technology is in commercial use through license agreements or direct commercialization in the fields of wound care, urology, spine, and sports medicine.

ICU Medical connects patients and caregivers through safe, life-saving, life-enhancing IV therapy systems, software, solutions, and consumables. Since IV therapy is our only business, meeting your IV needs with quality products and consistent supply is our only concern. We are 100% focused on bringing you intuitive, patient-centric IV products and services that provide meaningful clinical differentiation, consistent innovation, and superior value. We design our products to work within your existing workflows to minimize disruption and maximize the time you spend with patients. Together, we help forge the human and emotional connections that enhance clinical experience and are the essence of outstanding quality of care. For more than three decades, we have been dedicated to a singular purpose—improving the safety and efficiency of IV therapy. With the acquisition of Hospira Infusion Systems from Pfizer in 2017, we became the only company to focus exclusively on IV therapy across the continuum of care. Our focus allows us to bring you: > Dedicated and non-dedicated IV sets and needlefree connectors clinically proven to provide an effective barrier against bacterial transfer and colonization. > The industry's broadest IV smart pump offering covering large volume, pain management, and ambulatory needs. > IV medication safety software providing full IV-EHR interoperability with the highest customer satisfaction and compatibility with more EHR systems than any other company. > Significant US IV solutions manufacturing and supply capabilities.

Imperative Care is a Silicon Valley-based medical technology company researching and developing connected innovations to elevate care for people affected by devastating vascular diseases such as stroke and pulmonary embolism. The company has four businesses focused on addressing specific gaps in treatment and care to make an impact across the entire patient journey. Follow Imperative Care Stroke, Imperative Care Vascular, Telos Health and Kandu Health for product and business-level updates.

Innoblative is a private medical device company addressing clinical unmet needs for patients with breast cancer and other soft tissue diseases. We are developing advanced energy-based surgical solutions to help improve the way surgeons coagulate and ablate soft tissue to achieve better care for patients. Innoblative has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for the company's SIRA® RFA Electrosurgical Device. The SIRA® device is investigational for use in BCS and is not yet available for sale in the United States. The SIRA® device is cleared for intraoperative coagulation and ablation of soft tissue.

InterVene is a medical device start-up company reinventing the way physicians treat severe venous disease in the legs. InterVene's BlueLeaf(TM) Endovenous Valve Formation System represents the first ever non-implantable, endovenous approach to deep vein valve failure. This technology allows physicians to create new vein valves for patients who are unable to efficiently pump blood out of their legs and back to their heart. Millions of Americans currently suffer from painful venous stasis ulcers (VSU’s) and other costly and devastating symptoms, yet no minimally invasive therapy exists to treat deep vein valve failure, one of the most prevalent underlying causes of these symptoms. InterVene plans to change that. InterVene was originally a product of the Stanford Biodesign Fellowship and is a former Company In Residence at the Fogarty Institute for Innovation. InterVene's offices are now located in South San Francisco near SFO airport.

Intuitive (Nasdaq: ISRG), headquartered in Sunnyvale, Calif., is a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery. At Intuitive, we believe that minimally invasive care is life-enhancing care. Through ingenuity and intelligent technology, we expand the potential of physicians to heal without constraints.

At Pacira Biosciences, Inc., we are driving innovation to provide ways to manage pain safely and effectively. iovera° is a patented, 510(k)-cleared medical device, which uses targeted cryoanalgesia for immediate and long-lasting pain relief. iovera° treats peripheral nerves to temporarily stop pain signals for up to 90 days and provides pain relief until the nerve regenerates and nerve signaling is restored through an innovative handheld design. The iovera° system is used to destroy tissue during surgical procedures by applying freezing cold. It can also be used to produce lesions in peripheral nervous tissue by the application of cold to the selected site for the blocking of pain. It is also indicated for the relief of pain and symptoms associated with osteoarthritis of the knee for up to 90 days. The iovera° system is not indicated for treatment of central nervous system tissue. iovera° should not be used for people with: cryoglobulinemia, paroxysmal cold hemoglobinuria, cold urticaria, Raynaud's disease, open and/or infected wounds at or near treatment site. Patients treated with iovera° (a needle-based therapy) may have certain reactions, including but not limited to bruising, swelling, inflammation and/or redness, local pain and/or tenderness, altered feeling at application site. Proper iovera° use (see User Guide) can help reduce or prevent these reactions: in treatment area(s) – skin damage from being exposed to cold/heat, skin darkening/lightening, skin dimples; outside treatment area(s) – muscles may not work/move normally. Adverse event reporting: email drugsafety@pacira.com or call 1-855-793-9727. Product quality complaints: email drugsafety@pacira.com or call 1-800-442-0989. Please don't report such information through this or other social media pages owned by Pacira Biosciences, Inc. If you do report through this page, Pacira reserves the right to contact you for information.

IRIDEX is a worldwide leader in developing and manufacturing innovative and versatile light-based medical systems and delivery devices to treat glaucoma and retinal diseases. We maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. We are dedicated to a standard of excellence, offering superior technology for superior results. Our products are sold in the United States and Germany through a direct sales force and in over 100 countries through a network of approximately 70 independent distributors. Some of our products include the Cyclo G6 glaucoma laser, IQ 577 retinal laser, IQ 532 retinal laser, and TxCell scanning laser delivery device. Learn more at iridex.com

Isto Biologics was formed in 2016 when St. Louis-based Isto Technologies and Arteriocyte Medical Systems Inc. of Hopkinton, Massachusetts, joined forces under the Isto Holdings umbrella. Isto Biologics is focused on offering evidence-based solutions for bone regeneration and cell therapy to help improve patient outcomes. The company's best-in-class product offerings include Arteriocyte's market-leading Magellan® Autologous Platelet Separator and Isto's bone-growth and cell-therapy products including InQu® Bone Graft Extender & Substitute; and Influx™, a natural bone-graft material.

IZI Medical is a prominent medical device manufacturer and distributor, specializing in minimally invasive diagnostic and therapeutic solutions. Founded in 1991 by a neuroradiologist and a radiation oncologist, the company is headquartered in Baltimore, Maryland. In 2022, IZI became part of Halma plc, operating as a standalone entity within Halma’s Healthcare sector. The company is dedicated to enhancing patient care through physician-inspired innovations and aims to improve the quality of life for patients. IZI Medical offers a diverse portfolio of 44 medical devices across four key markets: image-guided surgery, interventional oncology, interventional neuro and spine, and radiation therapy. Their products include tools for instrument navigation, tumor localization, and treatment planning systems. With over 100 active patents, IZI Medical emphasizes innovation in minimally invasive procedures. The company serves more than 2,500 hospitals in the U.S. and distributes its products to physicians in 35 countries, focusing on improving clinical efficiency and patient outcomes.

At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That’s why for more than 135 years, we have aimed to keep people well at every age and every stage of life. Today, as the world’s largest and most broadly-based health care company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. We are blending our heart, science and ingenuity to profoundly change the trajectory of health for humanity.

Corneal Surgery Devices

Kleiner Device Labs - Advancing Minimally Invasive Spinal Surgery™ During 25 years of active spinal surgical practice and over 6,000 surgeries, Dr. Jeffrey Kleiner became increasingly aware that instrument design and quality played a significant role in the clinical outcome of spinal surgery. He recognized key gaps in the instrumentation available to spinal surgeons and this led him to develop a series of innovative solutions. In 2013, Dr. Kleiner established Kleiner Device Labs to build and sell innovative spinal surgical products. These novel and advanced tools deliver improvements in efficiency and safety for patients and enable surgeons to perform more effective and less complicated fusion surgery. Kleiner Device Lab's first product, a Bi-Directional Graft Funnel (KG™1), works with any flowable biologic graft material, provides a more efficient and safer delivery vehicle for bone graft extenders, facilitates grafting in front of or alongside all types of interbody cages and can eliminate or reduce surgeon dependency on BMP. Building on the underlying philosophy behind the KG™1, Kleiner Device Labs developed the KG™2 Surge™ Flow-Thru Interbody Implant in 2021. No other device integrates implant positioning and graft delivery like the KG™2 Surge™. The system not only maximizes successful outcomes for patients (while simplifying the procedure for surgeons) but reduces costs for healthcare providers and insurers as well. Kleiner Device Labs has a broad patent portfolio and a runway of innovative minimally invasive spinal surgical products. These strategies are equally effective in open theater surgical technique as well.

LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. The company is listed on NASDAQ.

Levee Medical, Inc. designs, develops, and manufactures innovative urological devices with the focus of improving recovery outcomes post-prostatectomy so that patients can quickly and confidently return to normal activity. The company's inaugural product is designed to support and stabilize the post-operative bladder neck and urethra following prostatectomy to accelerate the return of continence and reduce the overall risk of chronic incontinence.

Lifecore Biomedical is a full-service contract development and manufacturing organization (CDMO) that partners with pharmaceutical and biotech companies to develop and deliver vital and complex injectable therapies. We're also a manufacturer of premium sodium hyaluronate. From formulation to commercialization, we have everything it takes to move your project to the next level, making progress possible for our partners, people and most importantly, patients. Working from state-of-the-art facilities, our people are subject matter experts, our capabilities customized, our processes and systems qualified and our infrastructure optimized to meet your most sophisticated requirements regardless of scale. Our expertise is in drug products that are challenging and difficult to formulate, sterile filter, and aseptically fill. We've been the global leader in pharmaceutical-grade sodium hyaluronate (NaHy) for nearly 40 years. Leveraging this experience alongside deep expertise and capabilities in highly viscous solutions, we create tailored solutions that solve your drug development challenges across the entire development and manufacturing lifecycle. Our capabilities: Sterile Injectable Development - Formulation Development - Sterilization Development - Process Development - Analytical Services & Stability - Engineering Services - Validation Services Sterile Injectable Manufacturing - Sterilization - Aseptic Filling - Packaging - Analytical Services & Stability

LSI SOLUTIONS®, located in beautiful Victor, New York, is a dynamic and growing medical device company that has more than doubled in size over the last seven years. - LSI SOLUTIONS® is dedicated to advancing minimally invasive therapeutics through research, development, manufacturing, and marketing proprietary products. - Company Mission: Our customer is ultimately a patient. Our technology challenges human illness. Our mission is to lead the world in surgical innovation and product delivery.

Lumendi is dedicated to improving healthcare through the development and application of medical technology that reduces the level of patient intervention and procedure time, positively impacts recovery rates and outcomes, and decreases costs to the healthcare system. Our approach will enable clinicians to perform existing procedures more efficiently and usher in a new era of incisionless therapies to treat conditions that previously required abdominal surgery. Founded in December 2014, Lumendi holds a worldwide exclusive license to certain intellectual property developed by Minimally Invasive New Technologies (MINT), a joint program of Weill Cornell Medical College and New York-Presbyterian Hospital. In collaboration with MINT and other partners, Lumendi is developing devices to enable less invasive endolumenal procedures in the GI tract, primarily in the colon. These devices have the potential to replace many invasive laparoscopic and open surgical procedures currently performed in the hospital setting, and may also facilitate performance of these procedures in the outpatient setting. We're also working on additional less invasive techniques that can lead to better patient outcomes and make procedures easier and more comfortable for clinicians. We partner with leaders in healthcare to understand their needs and the needs of patients, and work to develop new solutions that will improve their lives.

Machine Solutions is a provider of advanced equipment and services for the medical device, biopharmaceutical and blood- and plasma-collection industries. We have been persistent in our pursuit to add industry- leading technology leading to the unification of MSI, SteegerUSA, BW-TEC AG, Vante, PlasticWeld Systems, Crescent Design, Beahm Designs, Vela Technologies, SEBRA and Intec Automation to provide a breadth of products to support customer needs and growth. Machine Solutions provides proprietary mechanical solutions to a variety of complex process, testing and device design challenges. Our equipment has become the industry standard for balloon catheter pleat and folding, drug coated stent crimping, heart valve crimping, medical wire braiding and coiling, catheter lamination, marker band swaging, balloon forming, laser bonding, tube cutting and our thermal processing products are considered the foundational tool for a wide range of plastic manufacturing processes. As a pioneer in radio frequency technology, the company has continued to develop advancing technology for catheter tipping, bonding, flaring, flanging, hole forming, biopharmaceutical sealing, sterile connecting and disconnecting along with many other applications. Our testing products support customers to meet ISO 10555 general requirements for testing intravascular sterile use catheters with test equipment including hydraulic leak & burst testing, stent radial force testing, catheter trackability and torquability, stent securement and other testing services

Since 1981, Mastel Surgical has been a leader in precision micro-surgical instruments. Our ultrathin, minimally invasive diamond scalpel redefined ophthalmic surgery standards. Focused on innovation, quality, and service, we extend our expertise to sterile processing, delivering products that meet healthcare's daily demands. ISO certified (ISO 13485:2016 (MDSAP)), FDA-registered, and Health Canada Registered.

Medfix® International, LLC specializes in cost effective surgical solutions in each of our subspecialties. Our subspecialties include spine retractor systems, disc preparation systems and procedure specific instruments. We work directly with healthcare facilities and distributors, putting high-quality instrumentation in the hands of surgeons in over 57 countries. Our extensive product portfolio offers a single source for spine surgery instruments. We are able to service our clients with stock availability, short lead times, as well as competitive pricing. Medfix® manufacturing capabilities are able to meet demand at any level. Our focus is cost reduction without compromising quality.

MedGyn Products manufactures and distributes medical devices for the women's healthcare industry including disposables, high quality instruments and equipment to OB/GYN professionals around the world. Our focus on our corporate values has allowed us to continually grow for over two decades as one of the leading suppliers of medical devices for women. Commitment to Innovation We are continually evaluating our product portfolio to drive innovation in healthcare delivery for women. We focus on innovation by leveraging our relationships with professionals to understand procedural techniques and new product development opportunities. As a result, we have received numerous awards and hold several patents on our products. Commitment to Patients and Professionals We are committed to patients and professionals by constantly evaluating procedural techniques to identify products that are less invasive and more effective on women. Our focus is to improve the quality of life for female patients by offering the best medical device technology. Commitment to Our Diverse Team We have a dedicated employee base that is passionate about improving women's health. We strive to provide a collaborative environment to help our employees succeed. We also continually invest in education and training our team to improve our ability to provide superior customer service.

Meditrina is an innovative start up Company located in San Jose, CA, and founded in 2016 developed the Aveta™ hysteroscopy suite which was designed to provide physicians with the best care in their diagnosis and treatment of endometrial polyps and uterine fibroids. The system seamlessly integrates into any operating, procedure, or exam room. This new hysteroscopy system is an all-in-one platform which includes the single-use Aveta™ Pearl Hysteroscope for myomectomy, and the single-use Aveta™ Coral Hysteroscope for polypectomy procedures with integrated tissue resection and fluid management capability. The Aveta™ Pearl Hysteroscope is the first single-use hysteroscope to include full physician control providing proprietary fluid management and video control function directly on the hysteroscope handle.

MedSpark is a medical technology company that specializes in developing innovative medical devices.

Medtronic plc is an Irish medical device company. The company's operational and executive headquarters are in Minneapolis, Minnesota, and its legal headquarters are in Dublin, Ireland. Medtronic operates in more than 140 countries and employs over 90,000 people worldwide. The company is the world's largest standalone medical technology development company.

As a global healthcare company, we understand customer needs and innovate and deliver medical solutions that transform patient care. Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of proprietary disposable medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force and clinical support team totaling in excess of 300 individuals. Merit employs approximately 6,000 people worldwide with facilities in South Jordan, Utah; Pearland, Texas; Richmond, Virginia; Malvern, Pennsylvania; Rockland, Massachusetts; Aliso Viejo, California; Maastricht and Venlo, The Netherlands; Paris, France; Galway, Ireland; Beijing, China; Tijuana, Mexico; Joinville, Brazil; Markham, Ontario, Canada; Melbourne, Australia; Tokyo, Japan; Reading, United Kingdom; Johannesburg, South Africa; and Singapore.

Headquartered in Minneapolis, Minnesota, Metavention, Inc. is a privately held medical device company developing novel treatments for metabolic diseases

Micro-Leads is a medical device technology company developing injectable and laparoscopic, surgery-free devices for precision neurostimulation. Micro-Leads closed-loop platform reads the body's physiological response to stimulation and writes an adaptive stimulation therapy.

Sustainble Solutions That Enable High-Quality, Cost-Effective Care. Located in Beverly Mass, Microline Surgical develops and manufactures high-precision open and laparoscopic surgical instruments that enable surgeons across the globe to perform highly complex procedures with fewer complications, lower costs & better patient outcomes. Microline's laparoscopic reposable instruments provide a cost-effective and eco-friendly solution for today's OR. The MiFusion product line offers a broad spectrum of open and laparoscopic instruments used to seal and divide tissue utilizing proprietary Thermal Fusion technology. MiFusion devices use only pure heat and pressure so tissue damage is minimal and patient outcomes are vastly improved. Follow us on Twitter: @Microline_Surg Follow us on Facebook: https://www.facebook.com/MicrolineSurgical/ Follow us on Instagram: Microline Surgical

Mission: Manufacturing excellence through a commitment to quality, integrity, and servant leadership. Founded in 1988, Micropulse is a privately held, precision manufacturer focused on earning long-term partnerships with leading orthopedic companies built on trust, honesty, and open communication. Micropulse manufactures implants, instruments, cases and trays, and provides packaging and inventory management for orthopedic OEMs. Northeast Indiana has been home for the company since its inception. Customers can trust Micropulse to be a responsible, accountable, and committed partner backed by technology, capability, and scalability.

MicroSkin® is used in ALL Cymed pouching systems. It is a transparent, hypoallergenic polyurethane film. MicroSkin® offers a level of comfort and security unmatched by any other product on the market Designed with an emphasis on comfort and durability, at just 1/1000 of an inch thick and the ability to stretch up to 500%, the MicroSkin barrier accomplishes a comfort unparalleled with any other pouching system on the market.

With our proprietary processes and tools, Microspec has earned a global reputation for extruding the smallest, most complex medical tubing in the industry, with the tightest tolerances.

Since 1996, Minnetronix Medical has accelerated medical device breakthroughs as a design, development and manufacturing partner to leading device companies around the world. Today, through life-cycle efficiency, opportunity realization, and increased utility, the organization is creating value in key technology segments, including RF energy, fluid and gas management, optical systems, and stimulation and active wearables. From design and manufacturing services to whole product solutions, Minnetronix brings expansive industry insight and intentional technical acumen, delivering better medical devices to market, faster. Minnetronix is based in St. Paul, Minnesota. ​

Mizuho OSI is the leader in the markets for specialty surgery and patient positioning. The company’s portfolio includes specialty surgical tables for procedure-specific approaches that improve patient outcomes in spine and orthopedic surgeries along with disposable and reusable surgical patient care products.

Monteris is a private equity backed neurosurgical company focused solely on diseases of the brain. The company was founded in Winnipeg, Canada in 1999 to create neurosurgical technology that, when used by neurosurgeons, would allow them to ablate brain tumors and lesions that may be difficult to approach via traditional methods. The NeuroBlate® System is a minimally invasive robotically controlled laser thermal therapy that uses MRI-guided laser light to ablate (destroy) unwanted tissue in the brain where a lesion, or abnormal tissue, originates. Monteris has offices in Minnetonka, Minnesota, USA and Winnipeg, Manitoba, Canada.

Movair is a medical technology company based in Austin, Texas, with a strong focus on respiratory therapies and life-supporting medical devices. Founded in 1992, Movair has a 30-year legacy of innovation aimed at improving patient quality of life through portable and user-friendly technologies. The company offers the LUISA Ventilator, a compact home ventilator designed for both adults and children, featuring high-flow oxygen therapy and telemedicine capabilities. Movair also specializes in developing devices that enhance therapy usability and patient independence, while actively engaging with regulatory processes to ensure compliance and market readiness. Movair's mission is to enable "continuous, effortless, and inspired breath" through its life-empowering respiratory solutions, targeting patients with chronic respiratory conditions and healthcare providers managing respiratory care in home settings.

MTI designs, manufactures, and sells surgery and exam chairs and tables, medical cabinetry, stools, and many related accessories for the Podiatry, Otolaryngology, Dermatology, Plastic Surgery, Oral Surgery, and Ophthalmology specialties. The continued challenge of combating rising healthcare costs and advances in ambulatory medical care has influenced MTI to develop an entire family of power chairs/tables, cabinetry, seating, and accessories to meet the needs of medical professionals and patients in order to help deliver and receive quality medical care at reasonable costs.

Nanofuse is a regenerative therapeutic that has the properties of replacing or "regenerating" human bone cells to form normal bone. NanoFUSE Biologics products contain the only bioactive glass that is FDA-Cleared to be combined with demineralized bone matrix (DBM). The regenerative efficacy comes from the osteoinductivity of the DBM component plus the osteopromotivity of the bioactive glass. Bioactive glass has been clinically proven for over 30 years but only until now has NanoFUSE Biologics used bioactive glass to create a revolutionary and patented regenerative therapeutic.

Nanospectra Biosciences is a medical device company that specializes in nanomedicine for selective thermal ablation, with their lead product aimed at treating prostate cancer tissue.

Navigation Sciences™ is a clinical-stage company developing the NaviSci™ System for the tissue conserving removal of lung cancer and other soft tissue tumors. The system integrates Augmented Reality (AR) and advanced software with surgical instruments to guide precise surgical resection by enabling for the first time, real-time in-vivo margin measurement. The system aims to improve surgical outcomes with cutting-edge technologies that – reduce recurrence risk and conserve lung function – shorten hospital length of stay and enhance surgical workflow.

NeoChord is a privately held medical technology company leading the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation. The company's flagship product, the NeoChord Artificial Chordae Delivery System, received CE market clearance in December 2012.

Neocis, the first dental robotics company, is committed to enhancing dental surgeons’ capabilities and advancing patient care. Or Yomi is bringing the power of surgical robotics to dentistry.

Neuraptive Therapeutics is a medical technology company that specializes in bringing novel therapeutic technology for the acute surgical repair of injured peripheral nerves.

Reimagining. Redesigning. What are the possibilities when it comes to sustainability for the future and innovation for today? That's what we ask ourselves at NewGen Surgical. Founded in 2012 in the San Francisco Bay Area, and recipient of the California Product Stewardship Green Arrow Award for circular economy innovation, NewGen Surgical develops healthcare products that minimize environmental impact without clinical compromise, protecting the foundation of all health - our environment. NewGen Surgical offers the world's first upcycled, plant-based medical devices for the O.R. that minimize plastic, fossil fuel dependency, CO2e and chemicals of concern. Over 1,000,000 products have been delivered to date, equating to 42 tons of plastic and 48 metric tons of carbon eliminated from the healthcare supply chain.

Noah Medical is a medical technology company based in San Carlos, California, founded in 2018. The company specializes in developing advanced medical robotics aimed at enhancing diagnostic procedures in pulmonology. Its flagship product, the Galaxy System, is a robotic platform that integrates real-time navigation, augmented fluoroscopy, and tomosynthesis to improve the accuracy of lesion localization, which is vital for early lung cancer diagnosis and treatment. With a team of over 150 engineers and industry experts, Noah Medical leverages extensive experience from leading healthcare companies. The company's mission focuses on saving lives through early diagnosis and treatment, particularly in robotic navigated bronchoscopy. Noah Medical has received recognition as a "Fierce 15" company of 2023 and has raised $150 million in funding to support its innovative approach. Its technology is designed to enhance procedural efficiency and diagnostic accuracy in healthcare facilities, particularly in pulmonology and oncology.

Noleus Technologies is a Houston-based medical device company focused on developing and commercializing innovative technologies based on a platform to reduce swelling and to improve outcomes post-surgery. Our first product aims to establish a new standard of care for post-operative ileus through our differentiated and proprietary technology to reliably accelerate the return of bowel function after abdominal surgery.

nView medical, based in Salt Lake City, UT, is a startup whose mission is to make surgery safer, faster, and consistently accurate. nView develops imaging technology — bringing breakthrough AI solutions for image creation, image processing, and image visualization to surgery and interventional radiology. nView medical backers include the National Science Foundation (NSF), the National Institutes of Health (NIH), the State Of Utah, the National Capital Consortium for Pediatric Device Innovation, MedTech Innovator, HealthTech Arkansas, Dr. Kevin Foley, M.D., and Fusion Fund (Palo Alto, CA). Its founder, Cristian Atria, has had a progressive career with GE Healthcare in positions that range from development engineer to general manager with P&L responsibility. He has successfully assisted start-up and public companies with technology transfers, licensing, product development, regulatory approvals, and commercialization.

touchOPHTHALMOLOGY are a leading provider of learning resources, congress highlights and CME accredited activities for ophthalmologists.

Ocutrx Technologies, Inc. is a high-tech company that specializes in augmented reality (AR), extended reality (XR), and 3D visualization technologies. They develop innovative solutions for various sectors, including medical, military, consumer, and enterprise applications. Ocutrx aims to enhance how users interact with visual data, focusing on improving situational awareness and accessibility for visually impaired individuals. The company offers several products, including the OcuLenz AR/XR headset, which assists patients with advanced macular degeneration and is also suitable for gaming and telemedicine. Their ORLenz system enhances surgical visualization, allowing surgeons to interact more effectively with patient data. Ocutrx also provides customizable AR/XR platforms for developers and enterprises, promoting productivity and immersive experiences. Ocutrx serves a diverse range of customers, including healthcare professionals, military personnel, and developers creating AR/XR applications. The company holds over 25 patents related to AR/XR innovations, particularly in healthcare, showcasing their commitment to advancing technology in this field.

OD-OS aims to set new standards of care for retina treatment. By extending our innovative Retina Navigation platform, our goal is to become the global leader in novel therapeutic solutions for the growing number of people suffering from retina diseases. Join the Navilas mailing list: https://tinyurl.com/od-os-mailing-list Follow us on Twitter: https://twitter.com/OD_OS_Navilas Privacy Policy Social Media Pages: https://www.od-os.com/legal-notice-container/privacy-policy/social-media

Okami Medical, Inc. is a medical device company focused on developing innovative solutions that address key unmet clinical needs in peripheral vascular intervention.

OmniGuide's corporate culture has grown from the roots of an innovative idea from MIT to a global company that has successfully adapted to changes in the market. INSPIRATION Our purpose is to help reduce complications, every day. We achieve this with our creative energy and enthusiasm for fresh ideas. Our motivation is to continually remind ourselves that when we get up in the morning, patients who need our therapies are counting on us. EXCELLENCE The pursuit of excellence lies at the heart of everything we do. We are builders, redefining what it means to support great outcomes. We have the courage to think different and will ensure that OmniGuide remains committed to ideas that benefit patients and their outcomes.

Onkos Surgical is a privately held, specialty medtech company founded in 2015 that uses a digital platform and patient imaging analysis, to reconstruct bones following cancer therapy using personalized surgical planning and 3D printing.

Orchestra BioMed biomedical innovation company focused on developing transformative therapeutic products for large unmet clinical needs in procedure-based medicine.

Commercial stage medical device company, bringing together an elegantly simple evolution to robotic suture delivery and removal, with the best people in the medical device industry.

Orthofix is a global medical technology company headquartered in Lewisville, Texas. By providing medical technologies that heal musculoskeletal pathologies, we deliver exceptional experiences and life-changing solutions to patients around the world. Orthofix offers a comprehensive portfolio of spinal hardware, bone growth therapies, specialized orthopedic solutions, biologics and enabling technologies, including the 7D FLASH™ navigation system. 𝗢𝘂𝗿 𝗩𝗶𝘀𝗶𝗼𝗻: To be the unrivaled partner in MedTech, delivering exceptional experiences and life-changing solutions. 𝗢𝘂𝗿 𝗠𝗶𝘀𝘀𝗶𝗼𝗻: We provide medical technologies that heal musculoskeletal pathologies. We enable our teams through opportunities for growth, ownership of responsibilities, and empowerment to execute. We do this for patients and the healthcare professionals who treat them. We collaborate with world-class surgeons and other partners to bring to market highly innovative, cost-effective, and user-friendly medical technologies through excellent customer service. We do this to improve people’s quality of life and, in doing so, create exceptional value for our customers, employees, and stockholders. 𝗢𝘂𝗿 𝗩𝗮𝗹𝘂𝗲𝘀: • Take Ownership • Innovate Boldly • Win Together Join our mission to revolutionize musculoskeletal care and be a part of innovation that changes lives. Start your journey now at https://orthofix.com/about/careers/.

OrthoNovis is a medical device company that offers physicians and healthcare facilities the ability to purchase high quality products direct from the manufacturer. The OrthoNovis "direct to consumer" business model allows us to deliver innovative products at a price below other comparable products in the market. That is our GoDIRECT® Advantage!

Paragonix Technologies is a rapidly growing medical device manufacturer that designs, manufactures, and sells organ transplant transport devices. Our dynamic team is committed to improving the lives of transplant patients by providing advanced technologies to ensure optimal preservation for donor organs on the journey to their ultimate recipients. Our primary offices are located in Waltham, MA.

PAVmed (NASDAQ: PAVM) is a highly-differentiated, multi-product medical device company employing a unique and proven business model designed to advance products from concept to commercialization much more rapidly and with significantly less capital than the typical medical device company. This model enables us to pursue an expanding pipeline strategy with a view to enhancing and accelerating value creation.

Perimeter Medical Imaging AI is a pioneering medical technology company driven to transform cancer surgery with advanced imaging tools. We can't imagine how frustrating it is for surgeons to do everything they can and still have to make the "dreaded call" to the patient. That's why we developed our OCT technology that provides 10x the resolution of X-ray and ultrasound at 2mm imaging depth for real-time insight, so surgeons can act in the moment with greater certainty. A Toronto-based company established in 2013, with U.S. headquarters in Dallas, Texas, Perimeter seeks to harness the power of big data, artificial intelligence, and machine learning technology to further our mission of improving the standard of care, providing better long-term outcomes for patients, and reducing healthcare costs.

With Planatome® Technology, the surgical experience has changed for both the surgeon and the patient. Our improved scalpel blades have been crafted to provide a smooth, consistent, and precise cutting surface by eliminating the grind defects found on all standard scalpels, thus minimizing surgically induced tissue trauma. Planatome Technology will provide surgeons with a more precise incision with better consistency from blade to blade, while contributing to enhanced surgical outcomes, such as faster healing with reduced infections, increased wound strength with reduced scarring, and less pain with reduced nerve damage. Planatome Technology provides an extraordinary tool for the hands of an exceptional surgeon.

We are experts in plasma energy with pioneering research in medical plasma technology and a robust patent portfolio. Our company was formed by technology leaders inspired by the potential to transfer the principles of plasma physics and apply these in medicine. From this, a new standard in surgery was born – plasma surgery – and with it, PlasmaJet - the first true plasma surgery system. This important advancement is helping surgeons perform better surgery and maximize clinical benefits for their patients. PlasmaJet has been used to treat more than 45,000 patients in more than 20 countries all over the world. Our Products have proven results and unique value supported by a large clinical database. For more information, please visit www.theplasmajet.com Indications for Use: PlasmaJet System produces plasma energy for dissection, cutting, coagulation and the removal of soft tissue by vaporization in open and videoscopic procedures.

Polares medical is a medical device company with a novel device for treating mitral valve regurgitation.

PROCEPT BioRobotics is a medical robotics company that specializes in minimally invasive robotic surgery technology.

Procyrion is dedicated to improving outcomes for patients with cardiac and renal impairment using its catheter-deployed pump technology to address conditions with significant unmet needs. Aortix™ is a percutaneous mechanical circulatory support device that treats cardiorenal syndrome with a rapidly-deployed intra-aortic catheter-based system. Aortix™ is currently in the research and development phase and is not available for sale in any country. (Caution: investigational device. Limited by federal law to investigational use.)

In the simplest sense, we're a company that creates solutions. More specifically, we design novel access device technology for neurovascular interventions and unmet clinical needs. Because in the precious seconds that surround a stroke emergency, clinicians need technology that delivers. That's where we come in.

Collagen Matrix is now Regenity Biosciences. Regenity Biosciences advances new frontiers in regenerative science, turning bioabsorbable materials into life-changing solutions. Sought after for our novel resorbable technologies and distinct approach to contract manufacturing and contract development, our team brings the urgency and vision to deliver breakthrough medtech solutions for medical technology and medical device manufacturers of all sizes. Company Background For more than 25 years, Regenity Biosciences has been transforming bioabsorbable materials into regenerative solutions to repair and regenerate tissue and bone we have since introduced numerous bioresorbable technologies with more than 71 product lines commercially available worldwide. Most recently, Regenity expanded its product portfolio to include versatile bioresorbable polymer technologies via the acquisition of Polyganics, which was the impetus behind the new name and brand direction. Regenity is headquartered in Paramus, New Jersey, with manufacturing locations in Oakland and Allendale, New Jersey and Groningen, the Netherlands. Mission & Values Every day, we work to make a material difference in the lives of patients. With people’s health on the line, it’s our duty to act with urgency and diligence. It is this collective ethos that drives us each day to push the boundaries of what’s possible in tissue repair and regeneration. Looking for a Career with Purpose? Join our team and work with us to develop life-changing products that help patients heal. Visit our website to learn more about what sets Regenity apart. www.Regenity.com CMIContact@CollagenMatrix.com

Founded in 2006 with offices in Minneapolis, MN and Sunnyvale, CA, Relievant Medsystems is a privately held medical device company developing new solutions to improve the quality of life for millions of patients suffering from chronic vertebrogenic low back pain. Relievant’s Intracept® System delivers targeted energy into the spine and blocks the transmission of pain signals from the basivertebral nerve. This minimally invasive procedure provides spine surgeons and interventional spine physicians with a new way to provide clinically proven, durable pain relief for chronic vertebrogenic low back pain.

RenovoRx is a clinical-stage biopharmaceutical company focused on fighting cancer through the localized treatment of difficult to treat tumors via our proprietary RenovoRx Trans-Arterial Micro-Perfusion (RenovoTAMP®) therapy platform. RenovoTAMP utilizes approved chemotherapeutics with validated mechanisms of action and well-established safety and side effect profiles, with the goal of increasing their efficacy, improving their safety, and widening their therapeutic window. Our lead product candidate, RenovoGem, is a combination of gemcitabine and our patented delivery system regulated by the FDA as a novel oncology drug product to treat unresectable locally advanced pancreatic cancer (LAPC). Targeted therapy via RenovoTAMP platform safely and without transmission to non-targeted areas, is our primary focus. RenovoRx’s patent portfolio currently includes seven issued US patents and one European patent for ourtechnology with several additional patents pending in the US, Europe, and Asia. After demonstrating a median survival of 27.9 months in Phase 1/2 clinical trials vs. 12-15 months reported in historical studies for this patient population, RenovoRx secured two separate Orphan Drug Designations from the FDA for intra-arterial gemcitabine: pancreatic cancer and bile duct cancer (cholangiocarcinoma). This therapy is being further studied in the currently enrolling Phase 3 TIGeR-PaC clinical trial in pancreatic cancer and has a primary endpoint of overall survival and several secondary endpoints, including quality of life. The Phase 3 TIGeR-PaC clinical trial is enrolling unresectable locally advanced pancreatic cancer patients (LAPC) in the United States.

REVA Medical, LLC. is a leader in bioresorbable polymer technologies for vascular applications. REVA's lead product, Fantom Encore, is a drug-eluting bioresorbable scaffold for the treatment of coronary artery disease. Fantom Encore is made from Tyrocore, REVA’s proprietary tyrosine derived polymer. Unlike metallic stents, Fantom Encore is designed support the artery through the healing process, and then disappear (or “resorb”) from the body in order to restore natural function to the artery. Learn more at www.revamedical.com.

ReVivo Medical, LLC is an early-stage medical device development company. Our initial focus is on an array of implantable devices capable of improving treatments for back and neck pain. Our unique designs rely on the biomechanics of load sharing to promote bone fusion. They have been designed with the challenges of the surgical procedure in mind. Market Background. Lower back and neck pain are the leading causes of disability world-wide. In the United States alone, there are more than 465,000 spinal fusion surgeries (of all types) performed each year. Most conventional surgeries use interbody cages that fill the space between the vertebrae and plates (akin to splints) that are implanted to hold the vertebrae in place while the spine heals. Worldwide, the spinal fusion device market is $6.4 billion. With the current economics of medicine in the United States, additional challenges have been placed on spine surgeons. Reimbursement rates are reduced and are often tied to outcomes. Surgeons need to constantly improve their results and be more efficient in the operating room, thus they are seeking new products which add value while reducing cost. Customer Value Proposition. Our initial two flagship products, an interbody cervical cage and an anterior cervical plate are innovative, next generation designs. It is anticipated that they will:  Accelerate patient recovery time.  Reduce the complexity and time required for surgery.  Achieve manufacturing costs comparable to premium implants.  Have greater appeal than the commonly used PEEK material (for our cages).

S4 Medical is committed to developing solutions for safer and more effective catheter ablation treatment for atrial fibrillation.

SafeGuard Surgical provides biodegradable surgical devices that will ensure safer surgery for superior patient outcomes while reducing costs, preventing additional surgical interventions and reducing patient length of stay, but most importantly preventing mortality and morbidity which is much too common risk from surgery. Our mission is a scalable and sustainable innovative global outreach to improve surgical outcomes in advanced surgical procedures adapting US ideas in underdeveloped and advancing outcomes in contemporary nations.

Currently, SafetyFix is the one and only FDA approved removable bone screw on the market with patents in the US, Europe, Canada, China, & Australia. The SafetyFix EasyOut Removable Bone Screw can be used for bone fracture repair and other surgical procedures involving the foot, hand, wrist, ankle, elbow and other small bone corrective procedures. We believe no one should live with metal hardware in their body, which is why we have created the solution.

SalutarisMD is a medical device company that specializes in engineering a novel ophthalmic treatment for Wet age-related Macular Degeneration with a minimally invasive procedure.

With our focus on improving patient outcomes with evidence-based healing solutions, Sanara MedTech Inc. develops, markets and distributes surgical, wound care and skin care products to physicians, hospitals, clinics and all post-acute care settings. We are constantly seeking long-term strategic partnerships with a focus on products that produce efficacious outcomes at a lower overall cost. Our primary products are sold in the North American advanced wound care and surgical tissue repair markets. Sanara MedTech sells and distributes CellerateRX® Surgical Activated Collagen® Powder to the surgical market and BIAKŌS™ Antimicrobial Skin and Wound Cleanser, Irrigation Solution, and Wound Gel, HYCOL® Hydrolyzed Collagen, and PULSAR II™ Advanced Wound Irrigation System (AWI™) to the wound care market.

Sanovas, Inc. is a life science asset holding company that is developing and accelerating companies that create medical technologies which are advancing the next generation of minimally invasive surgical tools and technologies.

At Scientia Vascular, we believe that without access, therapy can not exist. Through cutting-edge innovation, we're answering our calling to radically disrupt the way diseases of the brain are treated. Our teams have been at the forefront of neurovascular systems, pushing beyond established boundaries to deliver the products physicians and patients need most.

SeaStar Medical is a commercial-stage medical technology company based in Denver, Colorado, focused on developing extracorporeal therapies to combat excessive inflammation in critically ill patients. Incorporated in 2020, the company aims to improve patient outcomes by transforming immune responses or removing harmful cytokines that contribute to organ failure. The flagship product, the Selective Cytopheretic Device (SCD), is designed to neutralize overactive immune cells and halt cytokine storms, which can lead to severe hyperinflammation. SeaStar Medical also offers QUELIMMUNE (SCD-PED), the first FDA-approved treatment for life-threatening acute kidney injury in critically ill pediatric patients. The company has received Breakthrough Device Designation for multiple therapeutic indications, facilitating a faster approval process. Led by a team of experienced professionals, including critical care physicians, SeaStar Medical targets critical care clinicians and hospitals, providing innovative solutions for managing severe inflammatory conditions.

Siemens Healthineersenables healthcare providers worldwide to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving patient experience and digitalizing healthcare.COVID-19: CE mark for its molecular Fast Track Diagnostics (FTD)SARS-CoV-2 Assay.

We are reimagining eyecare with transformative technology and an interventional mindset. We believe interventions should happen sooner to preserve, protect, or restore natural eye function. So, we aim to provide eyecare providers with transformative, clinically-proven therapies that are intuitive, less invasive, and more intelligent.

Signati Medical, Inc. based in Providence, Rhode Island is an early stage medical device company committed to developing its revolutionary, Sealed Vasectomy Procedure (SVP)™. Signati Medical is dedicated to advancing men's health and plans on launching its product platform in mid 2024.

Silk Road Medical, Inc. is a medical device company located in Sunnyvale, California, that is focused on reducing the risk of stroke and its devastating impact. The company has pioneered a new approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. For more information on the company, visit our website at http://silkroadmed.com/. The TransCarotid Artery Revascularization (TCAR) Procedure is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. The ENROUTE® Transcarotid Neuroprotection and Stent System are the first and only products specifically designed and indicated for TCAR in high surgical risk patients that need carotid intervention. For more information about the TCAR procedure and essential prescribing information, please visit http://silkroadmed.com/ifus/. For more information about carotid artery disease and the risks involved with any intervention (e.g. bleeding, death, myocardial infarction, restenosis, stroke, TIA, vessel dissection, vessel occlusion, etc.), please visit http://silkroadmed.com/disease-and-treatment-options/.

Silony Spine is disrupting the spinal surgery marketplace with compatible options for enabling technology systems. Check out our portfolio of precision tools and hardware that add significant value and freedom of choice.

SinuSys Corporation is a medical device company focused on developing new therapies to improve the sinus health of patients. The company’s first product, the Vent-Os™ Sinus Dilation System, is designed to resolve sinusitis symptoms in a simple, two-step interventional procedure. The device enables gradual dilation of the sinus ostia, which is intended to maximize patient tolerability of the procedure in an office setting under local anesthesia. Unlike balloon dilation devices that use rapid, high-pressure inflation, the Vent-Os Sinus Dilation System is a small, low-pressure, self-expanding insert designed to gently and gradually open the maxillary ostia. The Vent-Os System incorporates the Company’s proprietary osmotic technology, which utilizes the body’s natural mucosal fluids to expand the insert before removal. In an office setting, patients are comfortably relocated to the waiting room between insertion and removal of the device.

SkinCure Oncology is the only company offering GentleCure™—the most comprehensive approach to delivering advanced, nonsurgical treatment for basal cell carcinoma, squamous cell carcinoma, and other skin cancers using Image-Guided SRT. The company partners with quality-focused dermatologists and Mohs surgeons to bring cancer center-level radiation therapy to physician offices. From clinical, administrative, and operational backing to robust patient support, SkinCure Oncology ensures that practices are fully equipped to offer treatment with Image-Guided SRT. This advanced technology delivers calibrated doses of X-ray energy via the Sensus SRT-100 Vision™, the first and only skin cancer treatment platform with high-frequency ultrasound imaging. Adaptive radiotherapy protocols destroy malignant cancer cells while preserving healthy tissue surrounding the treated areas for optimal clinical and cosmetic outcomes and the ideal patient experience.

Smith & Nephew plc is a healthcare company that specializes in medical devices for orthopedics, wound care, and surgical equipment.

Sofregen is a manufacturer of a biomedical silk protein intended to facilitate soft-tissue bulking and regeneration for a range of procedures in medical aesthetics and other medical applications. Sofregen's Silk Voice®, a silk protein injectable implant & catheter, was cleared by the U.S. FDA in 2019 for vocal fold medialization and vocal fold insufficiency.

Solinas Medical is a medical device company that specializes in modernizing vascular access technology for hemodialysis, with a focus on reducing cannulation-related complications and healthcare costs.

Our mission is to provide the next generation of sound medicine through proven ablative technologies that precisely deliver care while sparing healthy tissue. This next generation of care involves expanding our current HIFU technologies to treat a range of urological indications that balance treatment effectiveness and quality of life.

ABOUT SONEX HEALTH "Refined simplicity" is the guiding principle behind Sonex Health, Inc., to drive efforts and innovations that result in elegant, effective solutions to some of the healthcare system's most pressing needs. Mayo Clinic physicians Darryl Barnes, MD and Jay Smith, MD and business operations expert Aaron Keenan founded Sonex Health in 2014. Sonex Health has developed UltraGuideCTR™ with Meerkat Technology™ to treat carpal tunnel syndrome through a less invasive approach while using real-time ultrasound guidance. Carpal Tunnel Release with UltraGuideCTR and real-time ultrasound guidance allows a procedure that once took place in an operating room to be safely and effectively performed in a surgery center or office setting, resulting in rapid patient recovery, improved cosmesis, and reduced costs. ABOUT UltraGuideCTR The low profile UltraGuideCTR™ with Meerkat Technology™ enables physicians to perform Carpal Tunnel Release surgery through a small wrist incision under real-time ultrasound guidance. CTR with ultrasound guidance relieves the symptoms of carpal tunnel syndrome while minimizing recovery time. Most patients can return to work and the activities in 3-6 days while enjoying immediate motion so they can focus on getting back to their lives and the activities they love. ABOUT UltraGuideTFR Performing trigger finger release with UltraGuideTFR and real-time ultrasound guidance allows for concurrent visualization of the internal structures of the palm and fingers. The ability to identify key anatomical landmarks via ultrasound supports a safe and successful transection of the pulley through a single small incision.

Sotelix Endoscopy is a privately held medical device startup focused on developing groundbreaking therapeutic endoscopy devices for minimally invasive treatments in the gastrointestinal tract. Sotelix Endoscopy is based in Baltimore, MD.

SpectraWAVE, located in Bedford, Mass., is a privately held medical device company founded in 2017 to provide unrivaled optical and computational insights to improve the treatment and outcomes for patients with coronary artery disease (CAD). CAD, the buildup of plaque in the wall of the arteries that supply blood to the heart, affects 18.2 million adults age 20 and older. In CAD patients that undergo percutaneous stent placement, it is estimated that one in five patients experience adverse events within two years. SpectraWAVE’s state of the art HyperVue™ Imaging System combines next generation DeepOCT™ images and near infrared spectroscopy (NIRS) with workflows optimized for the cardiac catheterization lab. The HyperVue Imaging System is intended for the imaging of coronary arteries and is indicated in patients who are candidates for transluminal interventional procedures. The NIRS capability of the system is intended for the identification of patients and plaques at increased risk of major adverse cardiac events. For more information and complete indications for use, please visit www.spectrawave.com.

Spineology's OptiMesh is the only conforming, patient specific lumbar expandable implant on the market. OptiMesh is delivered through the smallest insertion profile, dynamically conforms to a patient’s unique endplate morphology, and powerfully expands to one of the largest implant footprints available. Spineology’s OptiMesh features our unique Conform and Expand™ technology, enabling a custom anatomical fit for lumbar fusion surgical patients. OptiMesh is designed to overcome the challenges of static and mechanically expandable implants.

SpineSource is commencing the U.S. launch of the CATAMARAN™ SIJ Fusion System, patented and manufactured by Tenon Medical, Inc. (Los Gatos, CA). The titanium CATAMARAN™ SIJ engages the ilium and sacrum via a posteroinferior approach with two fenestrated pontoons joined by an osteotome bridge spanning the joint.  It's pontoons and bridge are packed with autograft harvested off the drill bit used to prepare the joint. Just one implant is required. This posteroinferior approach targets the dense aspect of the joint. It's entry point, angle and trajectory point away from critical neural and vascular structures. The Mission of SpineSource is to provide implant devices, service and expertise using the highest ethical standards to benefit hospitals and surgeons, assisting them to promote the healing and well-being of patients with spinal disorders.

STAAR Surgical Company (an S&P 400 midcap company trading under NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye has been dedicated solely to ophthalmic surgery for over 35 years. The company offers the EVO Visian implantable Collamer® lenses (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR's lens used in refractive surgery is called an Implantable Collamer Lens or "ICL"​. Over 1,00,000 Visian ICLs have been implanted to date. It also provides minimally invasive intraocular lenses (IOLs), including foldable IOLs for use in minimally invasive cataract surgical procedures; aspheric IOLs that produce a clearer image than traditional spherical lenses; nanoFLEX IOL, a single piece Collamer aspheric optic; and Toric IOLs for cataract patients, as well as preloaded injectors for use in cataract surgery. In addition, the company sells surgical products, and other related instruments and devices, as well as injector parts; and manufactures AquaFlow devices for the treatment of glaucoma. It markets its products to health care providers, including surgical centers, hospitals, managed care providers, health organizations, group purchasing organizations, and government facilities primarily under the STAAR, Visian, Collamer, CentraFLOW, AquaPORT, nanoFLEX, nanoPOINT, Epiphany, and AquaFlow trademarks. The company sells products directly through its sales representatives and independent distributors in more than 75 countries. STAAR Surgical Company was founded in 1982 and is headquartered in Lake Forest, California. Its manufacturing plant is located in Monrovia, CA.

Standard Bariatrics® is committed to creating superior Bariatric/Metabolic Surgery clinical and economic outcome solutions for Patients and Healthcare Providers. We are leading the charge to harmonize the sleeve gastrectomy procedure with the Titan SGS® Stapling Technology, an anatomy-based approach to sleeve gastrectomy performed laparoscopically. By working alongside bariatric surgeons, we are actively developing a portfolio of medical devices to assist surgeons in shaping the future of Bariatric Surgery.

Pioneering Endovascular Robotics | Global leader in robotic technologies to enhance the treatment of arrhythmias & perform endovascular procedures

Stratus® Medical's mission is to improve clinical outcomes for chronic pain patients by advancing RF technology for the treatment of pain. The Nimbus® RF Multitined Expandable Electrode, in combination with an RF Generator and Probe, are intended for use in radiofrequency (RF) heat lesion procedures for the treatment of pain. Nimbus creates a large volume and optimally shaped lesion. Nimbus provides faster procedure times, lower cost and reproducible and durable pain relief. The Nimbus RF procedure takes about 20 minutes and is completed in a procedure suite in the office, ASC or hospital outpatient department. Patients can be treated while awake with numbing medication or sedated, depending on physician and facility preference. Nimbus has 37 issued patents, several patents pending, is FDA cleared (class II) and is CE marked (class IIb). Nimbus has been utilized in over 250,000 patient treatments in the United States, Australia, Brazil, Canada, United Kingdom, and other countries. Stratus Medical also markets complimentary technology including Vesta®, Nimbus Probe and Nimbus Disposable Probe and has several exciting development projects underway. Copyright © Stratus Medical 2024 Nimbus®, Stratus® Medical & Advancing RF Technology for the Treatment Pain® are registered trademarks of Stratus Medical, LLC. *The Nimbus RF Multitined Expanandable Electrode is one treatment option for pain. Consult your physician for medical questions about your specific pain condition & treatment options. Nimbus RF results will vary. See IFU for full list of warnings and precautions.

Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 150 million patients annually. More information is available at stryker.com and careers.stryker.com. Facts: ● 2023 Sales: $20.5 billion ● Industry: Medical Instruments & Supplies ● Employees: 52,000 worldwide ● 40 years of sales growth leading up to 2020 ● 44+ Manufacturing and R&D Locations Worldwide ● $1.4 billion spent on research and development in 2023 ● ~12,900 patents owned globally in 2023 ● Products sold in ~75 countries ● Fortune 500 Company ● 7 consecutive years as one of Fortune's World's Best Workplaces Stryker’s social media community guidelines: https://www.stryker.com/content/m/legal/social-media-community-guidelines/en/index.html Notice Regarding Employee Conduct on Facebook/LinkedIn Meta/LinkedIn does not permit employers to verify or validate “employees” in the (META: “Works at” LinkedIn: “Experience”) section of users’ profiles. Please be aware that the views expressed by individuals on their personal accounts and do not necessarily represent the views of our company. If you encounter any issues with a person claiming to be our employee, we recommend using the “Report Profile” feature. If you’d like to report concerns to our Ethics Hotline, you may do so at: https://app.convercent.com/en-us/LandingPage/b6bb4e84-9fcb-ea11-a974-000d3ab9f296

Supira Medical, Inc. is a portfolio company of Shifamed, LLC., a highly-specialized medical innovation hub focused on developing advanced solutions that get to market faster, reduce risk, increase impact, and forge a path toward a world where all people are able to lead longer, healthier lives.

Helping Improve Patient Outcomes Surgilogix is a leading provider of human tissue allografts that support surgeons and physicians in their efforts to improve the quality of life for their patients. Our amniotic tissue allografts are used to cover, protect and heal wounds and our allograft bone is used to fill bone voids and defects.

Surmodics is the global leader in surface modification technologies for intravascular medical devices and a leading provider of chemical components for in vitro diagnostic (IVD) immunoassay tests and microarrays. Surmodics is pursuing highly differentiated medical devices that are designed to address unmet clinical needs and engineered to the most demanding requirements.

Suture Ease is a medical device company that focuses on innovative development and commercialization of devices for laparoscopic surgery.

CAUTION -– Investigational device. Limited by Federal (or United States) law to investigational use. SynerFuse is long-term pain management without the use of addictive opioids. SynerFuse combines two FDA-approved technologies and synergistically fuses both in order to attack the problem of long-term, post-surgery, lower back pain, with a preemptive, drug-free pain management system.

INNOVATIVE BONE GRAFTS BASED ON IMPROVED BIOACTIVE GLASS Synergy has identified an optimal bioactive glass particle with a spherical shape and a biomodal size range that has been shown to significantly improve bone healing. Synergy's BioSphere® particles have been engineered to maximize the bone healing potential of bioactive glass. Synergy Biomedical is a privately-held medical device company focused on bringing biomaterial based products to the orthopedic and spinal surgery markets. Synergy's BIOSPHERE Technology represents an innovative approach to advancing bone graft technology, and improving bone healing and patient outcomes. Synergy Biomedical welcomes inquiries from independent sales distributors with an understanding of orthopaedic and spinal surgery. We are looking for distributors with a proven track record who are willing to grow our bone graft market. Please visit our website for more information: www.synergybiomedical.com

Repair Mesh

TeDan Surgical Innovations (TSI) is a Texas-based medical device manufacturer founded in 2006, specializing in surgical access systems. The company designs high-quality retractors and instruments for spine, neuro, orthopedic, and cardiothoracic surgeries, focusing on enhancing surgical visibility and minimizing tissue trauma. TSI is headquartered in Sugar Land, Texas, and operates globally, with a European subsidiary established in Germany in 2023 to support the EMEA region. TSI's product offerings include specialized retractors that reduce incision size and tissue damage, as well as durable surgical instruments developed in collaboration with surgeons. The company holds multiple patents for its innovative designs, which aim to improve precision in complex procedures and reduce postoperative complications. TSI serves hospitals and surgical centers worldwide, emphasizing direct collaboration with healthcare providers to meet the evolving demands of surgery. The recent acquisition by Halma positions TSI for further growth in the global medical device market.

Since 2011, Tenex Health has pioneered minimally invasive relief for chronic tendon pain with a one-time ultrasonic treatment. Since 2012, more than 100,000 procedures using the Tenex Health TX technology have been performed. The device is designed for the removal of diseased soft and hard tissue and restoration of healthy musculoskeletal function. Our mission is to provide patients who suffer from chronic tendon pain with a minimally invasive solution to remove the cause of their suffering and get them back to the things they love and need to do with less downtime than traditional treatment methods or surgery. Using conventional ultrasound guidance and the breakthrough Tenex Health TX System, surgeons can quickly and precisely treat only the damaged tendon tissue, leaving the surrounding healthy tendon unharmed. Because the procedure uses ultrasonic energy applied with the TX MicroTip and typically no stitches or general anesthesia are required, there is minimal downtime. Individual results may vary. For more information, visit www.TenexHealth.com.

Delivering the latest innovation in sacroiliac joint surgical solutions, Tenon Medical is uniquely positioned to introduce a refined surgical option for patients with chronic sacroiliac joint pain that fail conservative care. The Catamaran™ SIJ Fusion System offers a patented new surgical solution that places a single implant directly into the SI joint. Tenon Medical is led by a powerful team with years of cumulative experience in designing and launching innovative surgical solutions that deliver a pathway to improved quality of life for thousands of patients.

ADVANCING HEALTHCARE WITH HEART CREATE YOUR FUTURE, AND OURS Here you grow your own way, you create to innovate, and learn as you go, alongside like minds who share the same commitment to the future of healthcare. We are proud to have launched global development programs to help our associates shape their careers alongside the future of healthcare. ENJOY A REWARDING AND MEANINGFUL CAREER As a team, we make a real difference to the health and wellbeing of our patients today, and leave a lasting legacy for tomorrow. Your time is dedicated to innovation, problem solving, teamwork and lifelong learning, as an integral part of our ever-curious, always committed, continually collaborative environment. We foster a growth mindset culture, embracing mistakes as an opportunity to learn, and celebrating the small wins along the way, so we can all grow together. FOR TERUMO, FOR EVERYONE, EVERYWHERE Whatever you do – marketing, engineering, sales or manufacturing – our teams look out for one another, respect and support each other in achieving our goals, and we value diversity and inclusion, empowering everyone to bring their authentic self to work. If you’re ready to advance healthcare with heart, we look forward to hearing from you.

Thompson Surgical Instruments, also known as Thompson Retractor, is a prominent manufacturer of surgical retractors. Founded by Dr. Richard C. Thompson in 1965, the company began with a patented table-mounted retractor and has since evolved under the leadership of Dan Farley, who established the company in 1983. The company specializes in designing and manufacturing table-mounted retractors that provide stable and controlled exposure during surgical procedures. These retractors enhance surgical efficiency and safety by allowing for hands-free operation. Thompson Surgical Instruments offers customizable systems tailored to various surgical needs, with all products proudly made in Michigan, USA. The company is recognized globally for its commitment to quality and customer service, providing support through multiple channels. Additionally, Thompson Surgical Instruments contributes to the community by donating a portion of its profits to charitable organizations across the United States.

Thrombolex is engaged in the design, development, and distribution of innovative endovascular catheters used in interventional procedures, particularly in pharmaco-mechanical catheter-directed thrombolysis (PM-CDT) in patients who suffer from arterial and venous thromboembolic (A&VTE) conditions. The Company is currently marketing seven (7) different FDA-cleared devices that are all based on the BASHIR™ Endovascular Catheter platform technology.

Toro Neurovascular develops proprietary catheter technologies that enable physicians treating stroke to achieve the best possible patient outcomes.

TranS1 is a pioneer in spine technology innovation and is focused on Building Better Pathways™ to the spine. Since its inception, TranS1 has designed, developed, and commercialized transformational approaches to the spine used by thousands of surgeons to minimize the damage associated with traditional surgical approaches. TranS1 believes that the process of Building Better Pathways™ to the spine starts with solving true unmet clinical needs and ends with creating a value-based solution for surgeons, patients, and the healthcare system. trans1.com/ifu MKT-52205.A

TransMedics was founded to address the growing need for healthier organs for transplantation. We are focused on transforming the standard of care – increasing organ utilization, improving patient outcomes, and reducing transplant costs. The Organ Care System (OCS™) platform is a revolutionary technology for preserving organs used in the treatment of end-stage heart, lung, and liver failure. The OCS is the first and only multi-organ platform to leverage proprietary core technologies across multiple organs.

Transmural Systems is a medical device company with a platform of innovative electrosurgical therapies and new treatment options for patients suffering from heart failure. Transmural Systems is a privately held company located in Andover, MA.

Treace Medical Concepts, Inc. is a medical technology company with the goal of advancing the standard of care for the surgical management of bunion deformities and related midfoot correction. Bunions are complex 3-dimensional deformities that originate from an unstable joint in the middle of the foot and affect approximately 67 million Americans1, of which Treace estimates 1.1 million are annual surgical candidates. Treace Medical has pioneered and patented the Lapiplasty® 3D Bunion Correction® system – a combination of instruments, implants, and surgical methods designed to surgically correct all 3 planes of the bunion deformity and secure the unstable joint, addressing the root cause2,3 of the bunion. At Treace Medical Concepts, Inc., our mission is to advance the standard of care for the surgical management of bunions and related midfoot deformities. Treace Medical offers the Adductoplasty® System, the Hammertoe PEEK Fixation System, the SpeedPlate™ System, and other ancillary The content herein is for informational purposes and intended for healthcare professionals only. Treace Medical Concepts, Inc. does not dispense medical advice. A surgeon should rely on his or her own professional clinical judgment when deciding whether to use a specific product when treating a particular patient. Prior to use of the device, the surgeon should refer to the instructions for use for complete indications, contraindications, warnings, and risks. Complete risk and benefit information: www.treace.com. Visit www.treace.com/privacy-policy for our Privacy Policy. Treace Medical will make an offer of employment only to individuals who have applied for a position using our official application. Be on alert for possible fraudulent offers of employment. Treace Medical will not solicit money or banking information from applicants. 1Nix S, et al. J Foot Ankle Res. 2010. 27:3:21. 2Dayton P, et al. J Foot Ankle Surg. 2016;55:567-71. 3Dayton P, et al. J Foot Ankle Surg. 2018;57:766-770.

TTI Medical specializes in video and digital camera adaptation onto surgical microscopes, ophthalmic slit lamps, and endoscopes. In addition, we are a distributor of Ikegami and Sony medical video cameras. We also manufacture various CO₂ laser accessories, fiberoptic handpieces, and re-usable suction/irrigation instruments. TTI Medical was established in 1984 with the mission of designing and marketing high quality, technologically advanced surgical instruments and medical devices. Our product design criteria must pass critical tests for performance, convenience, dependability, and cost containment. Product quality is held to the highest standards. Opportunities within the medical marketplace are constantly being identified and evaluated for new product development. Patents protect the proprietary technology utilized in the ACCU-Beam® and ACCU-Surg® product lines. The fundamental principal of “universality” is incorporated in each product design. Universality ensures the end user of maximum utilization at the lowest possible cost. Our philosophy of producing high quality reusable surgical devices focuses on the cost containment criteria required within the hospital managed care environment. Our quality policy is to provide products that satisfy the requirements of our customers including regulatory, design, and cost specifications. Products shall be produced under a management system in compliance with quality standards of ISO 13485:2016, FDA 21CFR820, and the European Medical Device Regulation 2017/745. Our policy is to be in compliance with all regulations that apply to the products in countries where our products are distributed. Products shall only be released if they conform to specifications without functional defect.

United Biologics, Inc. is a California-based medical device manufacturer with over 22 years of experience. The company specializes in creating anatomically precise silicone vascular models for medical simulation, training, and device development. Located in Irvine, California, United Biologics serves leading medical device companies worldwide, particularly in the intravascular therapy market. The company produces silicone replicas of human vasculature, which are used for medical training, device research and development, and marketing purposes. These models provide realistic training environments for physicians and serve as cost-effective alternatives to animal testing. United Biologics is recognized for its exclusive focus on silicone vascular replication and is trusted by top-tier medical device innovators.

UroViu Corporation's mission is to revolutionize the cystoscopy platform for improved patient care and efficiency and has operations in California and Washington and production facilities in Asia. UroViu is the developer of the always ready cystoscopy platform, the most portable, self-contained and versatile single-use cystoscopy solution on the market. The intuitive portable platform and product suite are protected by a portfolio of 13 granted and many more pending patents. UroViu's vision is to simplify the scope of patient care.

Medical Tube tipping, bonding and hole forming solutions from Vante and PlasticWeld enable our customers to make the world’s most precise medical devices.

Vascular Technology Incorporated (VTI) is a medical device company with over 30 years of experience in developing, manufacturing, and selling surgical devices. The company is ISO 13485 Certified and FDA Registered, ensuring adherence to high healthcare standards. VTI focuses on providing innovative solutions for operating rooms across various surgical specialties, including vascular surgery, reconstructive surgery, urology, GI endoscopy, neurosurgery, and robotic surgery. VTI's product offerings include intraoperative Doppler systems that provide critical sound information during surgeries, disposable Doppler probes that enhance convenience and safety, and the Remotely Operated Suction Irrigation (ROSI) system for robot-assisted surgeries. Their equipment is designed to support a wide range of surgical specialties and is utilized in critical care areas of hospitals. VTI also offers career opportunities in research and development, engineering, and manufacturing, emphasizing skills in communication, professionalism, and project management.

Vector Surgical is the global leader in tissue orientation devices that provide the most accurate designation of excised tissue margins in cancer surgery. Our devices integrate the needs of surgeons, pathologists and radiologists, providing tools that enable the highest level of care for their cancer patients. In the quest to provide the best possible care for cancer patients, leading hospitals and physicians are eliminating error and improving patient outcomes by using Vector Surgical's MarginMarker. Surgeons use the MarginMarker sterile ink kit to define margins of excised tissue while in the OR; the pathology lab receives a clearly marked specimen. Unlike suture or metal tags, MarginMarker inks completely define each margin plane, resulting in more accurate re-excisions and potentially lower cancer recurrence. CorrectClips provide secure orientation of excised tissue on the image. CorrectClips allow a complete view of tissue so that lesions are quickly located. The surgeon applies the sterile clips while in the OR. The clips are translucent on the image; only the letters indicating orientation show brightly. This is superior to metal tags, which block the view of tissue behind the tag, and which cast a shadow that also occludes visibility. The SilversteinWrap, a post-surgical, post-biopsy bias compression dressing, improves outcomes in breast surgery. Complications such as hematomas, ecchymosis and seromas are common following breast surgery; they can delay healing and adjuvant therapy. Validated with 25+ years of clinical use, the SilversteinWrap can improve patient satisfaction and help to prevent up to 24% of these complications.

VenoStent is a tissue engineering medical device company developing bioabsorbable polymer wraps for better outcomes in vascular surgery.

Virtual Incision is on a mission to simplify robotic-assisted surgery (RAS), so more patients and their surgeons can access its benefits every day. Headquartered in Lincoln, Nebraska, and holding over 200 patents and patent applications, the company is developing MIRA, the first-of-its-kind miniature, and highly accessible RAS platform. With MIRA, our goal is to make every operating room RAS-ready. MIRA is currently in FDA clinical trials under an Investigational Device Exemption (IDE) and is being studied first for bowel resection, with additional potential applications to follow. https://virtualincision.com

Virtuoso's mission is to transform minimally invasive surgery by providing surgeons with dexterous, accurate, and cost-effective endoscopic robotic tools.

Viscus Biologics was founded in 2012 to help companies solve complex challenges ranging from ideation to high volume production. We are specialists in natural polymer and extracellular matrix materials, with the ability to develop and manufacture highly-specialized components, devices, and products needed to restore tissue to a healthy, functioning, and durable state. A LIFE SCIENCE PARTNER Whatever biomaterial needs you may have, companies can depend on Viscus Biologics for succesful product realization, quality manufacturing and timely distribution. With over ten years of operating excellence, we are thoroughly experienced with established procedures, policies, and a quality system to support product realization. PROVEN PROCESS The established D4 (Define, Discover, Develop, Deliver) process ensures that components, devices, and products are successfully realized and optimized for high performance. ROBUST SUPPLY CHAIN Our robust and domestic centered supply chain and partner network ensures consistency, cost-containment, availability, and timely delivery of components, devices, and products.

Founded in 2015, Visura is a medical device company dedicated to delivering state-of-art visualization solutions to improve the quality of transesophageal echocardiogram probe intubations. Visura has developed the TEECAD System, the world's first, FDA-cleared, disposable camera that seamlessly connects to a TEE probe, providing physicians real-time visualization for more efficient and effective probe placement.

Vitalcor, Inc. is a supplier of medical products used primarily in Cardio-Thoracic, Plastic, Nuero, and General Surgery. Vitalcor offers national marketing and selling program directed to surgical gatekeepers and decision makers at hospitals, freestanding sites and integrated healthcare delivery networks. We specialize in high-tech devices for several segments of surgery with a concentration in cardiac surgery.

At Vyaire, we know that each patient has different goals—and every breath counts to achieve them. We are a company on the move, relentlessly innovating, challenging the status quo and keeping patient needs at the forefront of everything we do to enable, enhance and extend lives. Established from legacy brands with a 70-year history of pioneering breathing technology, Vyaire Medical Inc. is a global company focused exclusively on supporting breathing through every stage of life. We pledge to evolve what’s possible to ensure every breath is taken to its fullest. We pledge to evolve what’s possible to ensure every breath is taken to its fullest. We accomplish this through our values: Patient Purpose, Customer First, Employee Success, and Corporate Integrity. The company’s origin began in the 1950s with the invention of the first mechanical ventilator and has since brought together well-known brands with proven track records of pioneering and advancing respiratory diagnostics and ventilation. Formed in 2016, the unified Vyaire established the world’s largest consortium of experts and industry leaders solely focused on the breathing continuum for customers and patients across the globe. Our passionate, dedicated global workforce consists of experienced breathing specialists who are inspired and empowered to elevate the quality of each inhale and each exhale. Vyaire acknowledges and celebrates the individual backgrounds, perspectives, and voices of our team members to best serve the diverse needs of patients and healthcare providers. Bring your unique talents, commitment, and career aspirations to our global team of dedicated professionals. Headquartered in suburban Chicago, Vyaire is recognized, trusted and preferred by specialists throughout the respiratory community worldwide.

Vycor Medical was founded on this basic mission: "There must be a better way." - A better way to access surgical locations without unduly damaging surrounding tissue - A better way to perform less invasive critical procedures, minimizing collateral trauma and accelerating postoperative recovery Vycor Medical is committed to improving patient outcomes by making brain and spine surgery procedures safer and more effective. The ViewSite Brain Access System (VBAS) is an innovative device designed to optimize surgical retraction and access to sites within the brain, reduce damage to the surrounding tissue, and accelerate patient recovery. VYCOR MEDICAL® is a registered trademark of Vycor Medical, Inc. VIEWSITE™, VIEWSITE BRAIN ACCESS SYSTEM™, and VBAS™ are all common law trademarks of Vycor Medical, Inc.

GOAL: DISPRUPT AND TAKE OVER AN OLD AND OVERLOOKED $150 MILLION/YR. MARKET BY LEVERAGING OUR SUPERIOR AND CLINICALLY PROVEN DEVICE DESIGN WHY IS IT POSSIBLE? Current oral airways have been continually proven to be defective and studies have proven that these common airways are not adequate to maintain the oropharynx airway. Further, they are not designed to control the ever-problematic tongue. Even more, our studies showed that current oral airways possess no proportional dimensional standards in relation to how it would impact the oropharyngeal area. THE PROBLEM The biggest impediment, after placement of an oral airway, is the relaxation of the soft tissue structures in the hypopharynx. These structures are inclined to collapse, thus obstructing airflow, while occurring from both front-to-back and side-to-side, thus greatly decreasing the size of the oral opening. In relation, literally every patient before and after anesthesia, CPR, or sedation, is provided with a manual jaw-thrust to prevent the tongue from falling back and obstructing the airway. Furthermore, almost every patient intubated is provided with an airway to prevent biting of the soft endotracheal tube. Both of these procedures involve manually protracting the lower jaw by pulling it forward relative to the upper jaw. SOLUTION Studies have proven that mandibular advancement increases the oropharynx opening under anesthesia, but nobody designed that embodiment into an oral airway, or thought to design an airway to also control the tongue…until now. INTRODUCING OUR LOWER-JAW THRUST (LJT) ORAL AIRWAYS WHICH ARE ENGINEERED TO INCREASE THE OPENING OF THE OROPHARYNX AIRWAY & CONTROL THE TONGUE

Wexler Surgical Inc. is dedicated to providing innovative high quality specialty surgical instrumentation. Wexler guarantees that all of our products have been manufactured by skilled instrument craftsmen using only quality materials. Wexler Surgical instruments comply with the European Medical Device Directives and bare the CE Mark. Our specialized manufacturing has allowed us to offer these quality products at competitive pricing while still providing the best customer service. In addition to our wide variety of instruments, we also offer metal and plastic instrument trays and products for instrument care. Wexler Surgical additionally provides an array of services that include: instrument customization, instrument repair, cross referencing, 30 day trials on our instruments and fantastic customer service which ranks among the top in the industry.

Xēnix Medical is a surgical implant company focused on the development of novel science-based solutions for patients requiring spinal fusion surgery. The company, headquartered in Orlando, Florida, markets its line of spinal implant devices in the United States through a network of independent distributors.

Xpan is Developing the Next Generation of Minimally Invasive Surgical Access Ports

Zeta Surgical is a digital surgery company based in Boston, Massachusetts, founded in 2018. The company specializes in enhancing the accuracy, safety, and accessibility of image-guided procedures through advanced navigation and robotics. Their flagship product, the RealTrack computer vision system, offers sub-millimeter precision and automatic registration, streamlining surgical workflows and improving efficiency in operating rooms. Zeta Surgical collaborates with leading hospitals and universities, including Massachusetts General Hospital and Brigham and Women’s Hospital, to integrate its technology into top medical institutions. The company has received multiple awards for its innovative designs, including the 2023 iF Design Award and the Integra Award for Innovation. Zeta Surgical's products are FDA 510(k) cleared and the company is ISO 13485:2016 certified, ensuring high standards in medical device quality management.